<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pmed</journal-id><journal-id journal-id-type="flc">plme</journal-id><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="doi">10.1371/journal.pmed.0030520</article-id><article-id pub-id-type="publisher-id">06-PLME-RA-0450R2</article-id><article-id pub-id-type="sici">plme-03-12-24</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Genetics and Genomics</subject>
          <subject>Obstetrics</subject>
          <subject>Public Health and Epidemiology</subject>
          <subject>Women's Health</subject>
        </subj-group>
        <subj-group subj-group-type="System Taxonomy">
          <subject>Obstetrics</subject>
          <subject>Genetics</subject>
          <subject>Epidemiology</subject>
        </subj-group>
      </article-categories><title-group><article-title>Angiotensin-Converting Enzyme I/D Polymorphism and Preeclampsia Risk:
          Evidence of Small-Study Bias</article-title><alt-title alt-title-type="running-head">ACE Polymorphisms and Preeclampsia</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Serrano</surname>
            <given-names>Norma C</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Díaz</surname>
            <given-names>Luis A</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Páez</surname>
            <given-names>Maria C</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Mesa</surname>
            <given-names>Clara M</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Cifuentes</surname>
            <given-names>Rodrigo</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Monterrosa</surname>
            <given-names>Alvaro</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>González</surname>
            <given-names>Adriana</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Smeeth</surname>
            <given-names>Liam</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Hingorani</surname>
            <given-names>Aroon D</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Casas</surname>
            <given-names>Juan P</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
          <xref ref-type="aff" rid="aff7">
            <sup>7</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1">
        <label>1</label><addr-line>Universidad Aut</addr-line>ónoma de Bucaramanga,
        Bucaramanga, Colombia </aff><aff id="aff2">
        <label>2</label><addr-line>Instituto de Ciencias de la Salud,
        Medell</addr-line>ín, Colombia </aff><aff id="aff3">
        <label>3</label>
        <addr-line>Universidad del Valle, Cali, Colombia </addr-line>
      </aff><aff id="aff4">
        <label>4</label>
        <addr-line>Universidad de Cartagena, Cartagena, Colombia </addr-line>
      </aff><aff id="aff5">
        <label>5</label>
        <addr-line>Universidad Industrial de Santander, Bucaramanga, Colombia </addr-line>
      </aff><aff id="aff6">
        <label>6</label>
        <addr-line>Department of Epidemiology and Population Health, London School of Hygiene and
          Tropical Medicine, United Kingdom </addr-line>
      </aff><aff id="aff7">
        <label>7</label>
        <addr-line>Centre for Clinical Pharmacology, Department of Medicine, at British Heart
          Foundation laboratories at University College London, London, United Kingdom </addr-line>
      </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Minelli</surname>
            <given-names>Cosetta</given-names>
          </name>
          <role>Academic Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">University of Leicester, United Kingdom</aff><author-notes>
        <fn fn-type="con" id="ack1">
          <p>NCS, LAD, MCP, RC, AM, LS, ADH, and JPC designed the study. NCS, LAD, MCP, CMM, AM, AG,
            LS, and JPC analyzed the data. NCS, MCP, CMM, RC, AM, AG, and LS enrolled patients. NCS,
            LAD, MCP, CMM, AM, AG, LS, ADH, and JPC contributed to writing the paper. MCP genotyped
            the insertion/deletion within the angiotensin-converting enzyme gene and collected the
            data for the meta-analysis.</p>
        </fn>
        <corresp id="cor1">* To whom correspondence should be addressed. E-mail: <email xlink:type="simple">nserrano@unab.edu.co</email> (NCS), <email xlink:type="simple">Juan.Pablo-Casas@lshtm.ac.uk</email> (JPC)</corresp>
      <fn fn-type="conflict" id="n102">
        <p> University College London holds patents on the measurement of asymmetric
          dimethylarginine in the management of preeclampsia.</p>
      </fn></author-notes><pub-date pub-type="ppub">
        <month>12</month>
        <year>2006</year>
      </pub-date><pub-date pub-type="epub">
        <day>26</day>
        <month>12</month>
        <year>2006</year>
      </pub-date><volume>3</volume><issue>12</issue><elocation-id>e520</elocation-id><history>
        <date date-type="received">
          <day>15</day>
          <month>6</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>10</month>
          <year>2006</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2006</copyright-year><copyright-holder>Serrano et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms
        of the Creative Commons Attribution License, which permits unrestricted use, distribution,
        and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
        <sec id="st1">
          <title>Background</title>
          <p>Inappropriate activation of the renin–angiotensin system may play a part in
            the development of preeclampsia. An insertion/deletion polymorphism within the
            angiotensin-I converting enzyme gene <italic>(ACE-I/D)</italic> has shown to be reliably
            associated with differences in angiotensin-converting enzyme (ACE) activity. However,
            previous studies of the <italic>ACE-I/D</italic> variant and preeclampsia have been
            individually underpowered to detect plausible genotypic risks.</p>
        </sec>
        <sec id="st2">
          <title>Methods and Findings</title>
          <p>A prospective case-control study was conducted in 1,711 unrelated young pregnant women
            (665 preeclamptic and 1,046 healthy pregnant controls) recruited from five Colombian
            cities. Maternal blood was obtained to genotype for the <italic>ACE-I/D</italic>
            polymorphism. Crude and adjusted odds ratio (OR) and 95% confidence interval
            (CI) using logistic regression models were obtained to evaluate the strength of the
            association between <italic>ACE-I/D</italic> variant and preeclampsia risk. A
            meta-analysis was then undertaken of all published studies to February 2006 evaluating
            the <italic>ACE-I/D</italic> variant in preeclampsia. An additive model
            (per-<italic>D</italic>-allele) revealed a null association between the
            <italic>ACE-I/D</italic> variant and preeclampsia risk (crude OR = 0.95
            [95% CI, 0.81–1.10]) in the new case-control
            study. Similar results were obtained after adjusting for confounders (adjusted
            per-allele OR = 0.90 [95% CI,
            0.77–1.06]) and using other genetic models of inheritance. A
            meta-analysis (2,596 cases and 3,828 controls from 22 studies) showed a per-allele OR of
            1.26 (95% CI, 1.07–1.49). An analysis stratified by study size
            showed an attenuated OR toward the null as study size increased.</p>
        </sec>
        <sec id="st3">
          <title>Conclusions</title>
          <p>It is highly likely that the observed small nominal increase in risk of preeclampsia
            associated with the <italic>ACE D</italic>-allele is due to small-study bias, similar to
            that observed in cardiovascular disease. Reliable assessment of the origins of
            preeclampsia using a genetic approach may require the establishment of a collaborating
            consortium to generate a dataset of adequate size.</p>
        </sec>
      </abstract><abstract abstract-type="toc">
        <p>The observed small increase in risk of preeclampsia associated with the<italic>ACE
          D</italic>-allele is likely to be due to small-study bias, a similar result to that
          observed in cardiovascular disease.</p>
      </abstract><abstract abstract-type="editor">
        <title>Editors' Summary</title>
        <sec id="sb1">
          <title/>
          <sec id="sb1a">
            <title>Background.</title>
            <p>Preeclampsia is a common condition affecting pregnant women worldwide; it is defined
              as the presence of increased blood pressure, together with protein in the urine.
              Although in many women preeclampsia may never result in symptoms, other women may
              experience headaches, problems with their vision, swollen ankles and feet, and other
              problems. Sometimes, preeclampsia progresses to eclampsia, in which potentially
              life-threatening seizures result. The causes of preeclampsia are not well understood,
              but several factors are known to contribute to the risk. These factors include
              diabetes, high blood pressure prior to pregnancy, obesity, and first pregnancy. There
              is also the possibility that preeclampsia has, at least in part, a genetic basis; the
              condition is more likely among women whose relatives have also had it. However, no
              definite genetic cause has yet been confirmed.</p>
          </sec>
          <sec id="sb1b">
            <title>Why Was This Study Done?</title>
            <p>A common variant in one particular gene, <italic>ACE,</italic> which codes for the
              angiotensin-1 converting enzyme, has been linked with preeclampsia in a number of
              different studies. The protein encoded by <italic>ACE</italic> is involved in
              controlling blood pressure and the balance of fluid and salts in the blood. However,
              many of the studies supposedly linking <italic>ACE</italic> and preeclampsia were done
              on very few participants. Small studies are more likely to generate “false
              positive” findings. Therefore, a group of investigators from Colombia and
              the UK wanted to find out whether they could reproduce the supposed link between the
                <italic>ACE</italic> gene variant and preeclampsia in a large study, and also to see
              whether the previous studies could have been “false
            positives.”</p>
          </sec>
          <sec id="sb1c">
            <title>What Did the Researchers Do and Find?</title>
            <p>These investigators carried out a case-control study. This means that women with
              preeclampsia (“cases”) were recruited, and compared with women
              similar in all other respects but who did not have preeclampsia
              (“controls”). In total 1,711 pregnant women from five Colombian
              cities were studied, of whom 665 had preeclampsia and 1,046 did not. Blood was taken
              from each participant and used for DNA sequencing of the <italic>ACE</italic> gene.
              The investigators then did a statistical comparison to see whether there was any
              association between preeclampsia and possession of a particular variant of the
                <italic>ACE</italic> gene. The results showed that there was no such association.
              Then, the investigators did a literature search to find all previous studies that had
              examined a possible link between variants of the <italic>ACE</italic> gene and
              preeclampsia. They found 22 studies reporting data obtained from 6,424 women (these
              figures include the results from the investigators' own case-control study described
              here). The data from all of these studies were then put together into a combined
              analysis. This combined analysis did suggest a small increase in the risk of
              preeclampsia in women with one particular variant in the <italic>ACE</italic> gene.
              However, this result was more likely in studies with small numbers of participants.
              Furthermore, the earliest studies done were most likely to show an effect, with the
              supposed link disappearing as more and more data were collected.</p>
          </sec>
          <sec id="sb1d">
            <title>What Do These Findings Mean?</title>
            <p>The findings presented here suggest that “small study bias” may
              explain the discrepancy between the results of the case-control study and the combined
              analysis. That is, studies involving few participants are less reliable and more
              likely to produce false-positive results. Therefore, it is possible that the proposed
              link between <italic>ACE</italic> gene variants and preeclampsia is a spurious one.
              The investigators propose that in future, collaborative research networks will be
              needed to carry out rigorous research on the genetics of preeclampsia. Such
              initiatives will help to overcome the problem of bias that can arise from small
              studies.</p>
          </sec>
          <sec id="sb1e">
            <title>Additional Information.</title>
            <p>Please access these Web sites via the online version of this summary at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0030520" xlink:type="simple">http://dx.doi.org/10.1371/journal.pmed.0030520</ext-link>.</p>
            <list list-type="bullet">
              <list-item>
                <p>Information for patients from<ext-link ext-link-type="uri" xlink:href="http://www.nhsdirect.nhs.uk/articles/article.aspx?articleId=431" xlink:type="simple">
                    NHS Direct (UK National Health Service)</ext-link> about preeclampsia.</p>
              </list-item>
              <list-item>
                <p>Medical encyclopedia entry on preeclampsia from <ext-link ext-link-type="uri" xlink:href="http://www.nlm.nih.gov/medlineplus/ency/article/000898.htm" xlink:type="simple">MedLine
                    Plus</ext-link>, supplied by the US National Library of Medicine.</p>
              </list-item>
              <list-item>
                <p>Information from the World Health Organization and Pan American Health
                  Organization on <ext-link ext-link-type="uri" xlink:href="http://www.paho.org/Project.asp?SEL=TP&amp;LNG=ENG&amp;ID=194" xlink:type="simple">maternal health in the Americas</ext-link>.</p>
              </list-item>
            </list>
          </sec>
        </sec>
      </abstract><funding-group><funding-statement>This project was funded by a grant from Universidad Autónoma de Bucaramanga
          (EGEN-10) awarded to NCS. LS holds a Medical Research Council Clinician Scientist
          Fellowship. ADH holds a British Heart Foundation Senior Fellowship. The funders had no
          role in study design, data collection and analysis, decision to publish, or preparation of
          the manuscript.</funding-statement></funding-group><counts>
        <page-count count="13"/>
      </counts><!--===== Restructure custom-meta-wrap to custom-meta-group =====--><custom-meta-group>
        <custom-meta>
          <meta-name>citation</meta-name>
          <meta-value>Serrano NC, Díaz LA, Páez MC, Mesa CM, Cifuentes R, et
            al. (2006) Angiotensin-converting enzyme insertion/deletion polymorphism and
            preeclampsia risk: Evidence of small-study bias. PLoS Med 3(12): e520. doi:<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0030520" xlink:type="simple">10.1371/journal.pmed.0030520</ext-link></meta-value>
        </custom-meta>
      </custom-meta-group></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Preeclampsia is a maternal disease of pregnancy associated with increased blood pressure
        and proteinuria after 20 weeks of gestation. It is a major cause of maternal and neonatal
        mortality and morbidity worldwide and has particularly high incidence in Latin American and
        Caribbean countries, in which hypertensive disorders during pregnancy account for
        25.7% of maternal deaths [<xref ref-type="bibr" rid="pmed-0030520-b001">1</xref>,<xref ref-type="bibr" rid="pmed-0030520-b002">2</xref>]. Preeclampsia
        is thought to be the result of the interplay between important genetic components and
        environmental influences; however, the factors and the mechanisms that lead to preeclampsia
        remain elusive [<xref ref-type="bibr" rid="pmed-0030520-b003">3</xref>].
        As a result, there is a lack of effective preventive interventions [<xref ref-type="bibr" rid="pmed-0030520-b004">4</xref>].</p>
      <p>With the exception of smoking, established risk factors for cardiovascular disease,
        including high blood pressure, diabetes, and obesity, are also risk factors for preeclampsia
          [<xref ref-type="bibr" rid="pmed-0030520-b005">5</xref>]. In addition,
        women who suffer from preeclampsia have an increased risk of later cardiovascular disease,
        which clearly suggests a shared aetiology [<xref ref-type="bibr" rid="pmed-0030520-b006">6</xref>].</p>
      <p>Inappropriate activation of the renin–angiotensin system may play a part in the
        development of many cardiovascular disorders, including preeclampsia [<xref ref-type="bibr" rid="pmed-0030520-b007">7</xref>,<xref ref-type="bibr" rid="pmed-0030520-b008">8</xref>]. A common insertion/deletion polymorphism
        within the angiotensin-I converting enzyme gene <italic>(ACE-I/D)</italic> has been reliably
        associated with substantial differences in the plasma and tissue angiotensin-converting
        enzyme (ACE) activity in a codominant (additive) fashion not only in persons of European
        descent, but also in other populations such as Hispanics [<xref ref-type="bibr" rid="pmed-0030520-b009">9</xref>–<xref ref-type="bibr" rid="pmed-0030520-b011">11</xref>]. Individuals carrying the <italic>D</italic> allele have higher ACE
        activity, which has been proposed as an intermediate phenotype of potential relevance for
        the development of high blood pressure and subclinical atheroma (i.e., higher intima-media
        thickness of the carotid artery) [<xref ref-type="bibr" rid="pmed-0030520-b010">10</xref>,<xref ref-type="bibr" rid="pmed-0030520-b012">12</xref>]. Despite the
        biological plausibility and the consistency of the effect of the <italic>ACE-I/D</italic>
        polymorphism on ACE activity, associations of the <italic>ACE-I/D</italic> polymorphism and
        coronary heart disease, coronary artery restenosis, stroke, and renal disease have been
        inconsistent [<xref ref-type="bibr" rid="pmed-0030520-b013">13</xref>–<xref ref-type="bibr" rid="pmed-0030520-b016">16</xref>].
        Moreover, systematic reviews and meta-analyses have indicated the presence of small-study
        bias in the published literature [<xref ref-type="bibr" rid="pmed-0030520-b013">13</xref>–<xref ref-type="bibr" rid="pmed-0030520-b016">16</xref>].</p>
      <p>Several studies, also usually small in size, have reported that women carrying the
          <italic>D</italic> allele of the <italic>ACE-I/D</italic> polymorphism have higher ACE
        activity and higher measures of uterine artery resistance, which is a marker for development
        of intrauterine growth retardation and preeclampsia [<xref ref-type="bibr" rid="pmed-0030520-b008">8</xref>,<xref ref-type="bibr" rid="pmed-0030520-b017">17</xref>]. These observations led to the proposal that the
        <italic>ACE-I/D</italic> polymorphism may be a good candidate in the search for a cause of
        preeclampsia. However, to date, studies evaluating the role of <italic>ACE-I/D</italic>
        polymorphism in preeclampsia have been individually underpowered to detect plausible genetic
        effect sizes, being much smaller than more recent studies in cardiovascular disease. We
        hypothesized that the published literature on the <italic>ACE-I/D</italic> polymorphism in
        preeclampsia might be similarly affected by small-study bias. To test this hypothesis, we
        conducted a new large genetic association study on the <italic>ACE-I/D</italic> polymorphism
        and preeclampsia in a geographical region with a high incidence of preeclampsia. We then set
        this study within the context of a systematic review and a meta-analysis of all studies
        conducted to date.</p>
    </sec>
    <sec id="s2" sec-type="methods">
      <title>Methods</title>
      <sec id="s2a">
        <title>Case-Control Study Participants</title>
        <p>A prospective case-control study was conducted in 1,711 unrelated young pregnant women
          (665 preeclamptic participants and 1,046 healthy pregnant controls) recruited from five
          Colombian cities at the time of delivery between January 2000 and December 2005. A verbal
          interview with a structured questionnaire was conducted by trained personnel at the time
          of the delivery to ascertain maternal age, gestational age, parity, smoking status during
          pregnancy, family history of preeclampsia, ethnic background, and socioeconomic position.
          On two separate occasions, the mean of two readings of blood pressure was obtained (four
          measurements in total) at the time of delivery. Blood pressure was measured in the right
          arm after a five-minute period of rest in a seated position using mercury
          sphygmomanometers or electronic devices calibrated against a mercury standard.</p>
        <p>A case was defined as a primigravid woman younger than 26 years old with blood pressure
          140/90 mm Hg or above, and proteinuria 0.3 grams or above in 24 hours, or a reading
          2+ or above on a dipstick in a random urine determination with no evidence of
          urinary tract infection after 20 weeks of gestation [<xref ref-type="bibr" rid="pmed-0030520-b018">18</xref>]. At least one control was recruited after
          each case within a window of 24 hours from the same hospital that provided the cases. A
          control was defined as a primigravid woman younger than 26 years old without preeclampsia
          and in labour after 37 weeks of pregnancy. To improve the homogeneity of the phenotype
          under evaluation, women with a prior history of autoimmune, metabolic (including diabetes
          or gestational diabetes), renal, or cardiac (including chronic hypertension) diseases were
          excluded from the study. All participants signed the informed consent document approved by
          the Ethics Committee from the Universidad Autónoma de Bucaramanga, Colombia.</p>
        <sec id="s2a1">
          <title>DNA extraction and genotyping.</title>
          <p>Blood was drawn from the antecubital vein into EDTA and samples stored at −50
            °C for DNA extraction, using the QIAamp DNA blood mini-kit (QIAGEN, Hilden,
            Germany). The <italic>ACE-I/D</italic> polymorphism in intron 16 was detected according
            to the method described by Rigat, et al. [<xref ref-type="bibr" rid="pmed-0030520-b009">9</xref>]. PCR is known to have a tendency to
            preferentially amplify the short deletion <italic>(D)</italic> allele in contrast to the
            larger insertion <italic>(I)</italic> allele in a competitive amplification reaction
            when both alleles are present, as occurs in individuals with the <italic>ID</italic>
            genotype. This leads to mistyping of <italic>ID</italic> individuals as
            <italic>DD</italic> in approximately 4%–5% of the
            samples. To avoid any mistyping of <italic>ID</italic> as <italic>DD,</italic> a second
            PCR amplification using insertion-specific primers was conducted for all participants
            who were homozygous for the <italic>D</italic> allele [<xref ref-type="bibr" rid="pmed-0030520-b019">19</xref>]. For a detailed description of the
            genotyping methods, see <xref ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>. All available DNA samples were genotyped and included in the
            present report, with no exclusions. For quality control, a random sample
            (<italic>n</italic> = 156) was subjected to a second PCR and genotyping to
            minimize any possible misclassification. The Cohen's kappa value among the samples
            regenotyped was equal to 0.95 (95% CI [confidence
            interval], 0.94–0.96), and the error rate was 2.56%
            (95% CI, 0.70–6.43). Genotyping was conducted blinded to the
            clinical status of the participants.</p>
        </sec>
        <sec id="s2a2">
          <title>Statistical analysis.</title>
          <p>To evaluate the presence of differences between groups, unpaired Student's t-,
              χ<sup>2</sup>, or Mann-Whitney tests were used as appropriate. A test for
            departure from Hardy-Weinberg equilibrium was performed by
              <italic>χ</italic><sup>2</sup> analysis. The principal a priori hypothesis was
            that the association between the <italic>ACE-I/D</italic> polymorphism and preeclampsia
            follows an additive model according to the number of <italic>D</italic> alleles. The
            additive “per-allele” model (in a log-scale) was based on the effect
            of the <italic>ACE-I/D</italic> variant on its intermediate phenotype (ACE activity),
            established in large studies and overviews as being a reliable association
              [<xref ref-type="bibr" rid="pmed-0030520-b010">10</xref>]. However,
            recessive and dominant models and multiple pairwise comparisons (<italic>ID</italic>
            versus <italic>II</italic> and <italic>DD</italic> versus <italic>II</italic>) were also
            evaluated for completeness as secondary outcomes.</p>
          <p>Multivariate analysis using logistic regression methods was also conducted to control
            for potential confounders (maternal age, ethnic background, place of birth of the women,
            recruitment centre, socioeconomic position, urinary or vaginal infections during
            pregnancy, and smoking status during pregnancy).</p>
          <p>To explore the prior hypothesis that the genotypic odds ratio (OR) is greater in women
            with an enriched phenotype, an analysis using an additive model was repeated for women
            stratified according to the presence of family history of preeclampsia (positive versus
            negative family history in mother or sisters), and disease severity with severe
            preeclampsia being defined as blood pressure above 160/110 mm Hg or proteinuria of 5
            grams or more in 24 hours, eclampsia, or the HELLP syndrome. For these analyses
            99% CIs were used to make some allowance for their exploratory nature. All
            statistical analyses were conducted using Stata, Version 9 (Stata Corporation, College
            Station, Texas, United States).</p>
        </sec>
      </sec>
      <sec id="s2b">
        <title>Meta-Analysis</title>
        <sec id="s2b1">
          <title>Search strategy and selection criteria.</title>
          <p>Electronic databases (MEDLINE, EMBASE, LILACS, KoreaMed, and Google Scholar) were
            searched up to February 2006 for all genetic association studies evaluating the
              <italic>ACE-I/D</italic> polymorphism and preeclampsia in humans in all languages. The
            search strategy contained both medical subject heading terms and text words as follows:
            “angiotensin-converting enzyme” or “ACE” or
            “peptidyl-dipeptidase A,” in combination with
            “pre-eclampsia” or “preeclampsia” or
            “pregnant hypertensive disorders” or “pregnancy
            hypertension,” and combined with “genetic” or
            “polymorphism(s)” or “mutation” or
            “genotype” or “gene(s).” No limits were used in
            the search strategy. We searched for any additional studies in the references of all
            identified publications, including previous relevant meta-analyses, and used the MEDLINE
            option “related articles” for all the relevant papers.</p>
          <p>For inclusion, studies had to involve unrelated women and examine the association
            between the <italic>ACE-I/D</italic> polymorphism and preeclampsia. Studies published as
            full-length articles or letters in peer-reviewed journals in any language were included,
            as well as abstracts taken from reference lists of identified publications. Authors were
            contacted (on at least three occasions) to obtain information on the genotype frequency
            by case-control status and by disease severity (severe and nonsevere preeclampsia), the
            use of blinding of genotyping staff to clinical status, the definition of outcomes, and,
            in a few cases, to clarify possible overlapping of study results. A positive reply was
            obtained in 15 out of 21 study authors contacted.</p>
        </sec>
        <sec id="s2b2">
          <title>Data extraction.</title>
          <p>The following information was extracted (entered into databases by two of the authors,
            JPC and MCP) from each study and disagreements resolved by consensus: year of
            publication, total cases, total controls, number of individuals by each genotype, study
            design, source of controls, matching variable, thresholds used to define preeclampsia,
            country of origin, ethnicity, <italic>χ</italic><sup>2</sup> goodness of fit for
            Hardy-Weinberg equilibrium and its <italic>p</italic>-value, use of blinding, mean age
            of participants, frequency of nulliparous women, and main exclusion criteria. In the few
            instances in which genotype frequencies provided by the investigators in tabular data
            differed slightly from published figures, the tabular data were used. Women with
            gestational hypertension were excluded from the present meta-analysis in order to
            improve the homogeneity of phenotype between studies.</p>
        </sec>
        <sec id="s2b3">
          <title>Statistical analysis.</title>
          <p>Data were analysed using Stata 9. The genetic model to be considered as the priori
            hypothesis was an additive model, following the considerations previously described for
            the case-control study. Secondary analyses involved ORs for other genetic models of
            inheritance such as recessive, dominant, and pairwise comparisons of the different
            genotypes. For all the models used, the <italic>D</italic> allele was considered the one
            at risk. For the additive or per-allele model, the OR was compared between cases and
            controls by assigning scores for different genotype groups and calculating ORs by
            logistic regression. We calculated the random effect summary OR and CIs for each
            polymorphism. To make some allowance for multiple comparisons 99% CIs were
            used for individual studies, and 95% CIs were reserved for the combined
            estimates. The inverse variance-weighted method was used to calculate the summary OR
              [<xref ref-type="bibr" rid="pmed-0030520-b020">20</xref>].
            Heterogeneity was assessed by the DerSimonian and Laird <italic>Q</italic> test and
              <italic>I</italic><sup>2</sup> was used as a measure to describe the percentage of
            variability in point estimates that was due to heterogeneity rather than sampling error
              [<xref ref-type="bibr" rid="pmed-0030520-b020">20</xref>]. Sources
            of between-study heterogeneity were explored using random effect metaregression models
            with restricted maximum likelihood estimation. The prespecified characteristics for
            assessment of sources of inter-study heterogeneity were: Study size (number of cases:
            &lt;100, 100–200, and ≥200); blinding of genotyping staff (blinded,
            unblinded, or unknown); disease severity (severe versus nonsevere preeclampsia);
            ethnicity of women evaluated (of European descent, Asian, Hispanic, Afro-Caribbean, and
            others); preeclampsia definition (adequate versus unclear); and publication language
            (English– versus non-English–language journals). Funnel plots of the
            effect estimate against the sample size, Egger regression asymmetry test, and a weighted
            (by the inverse of the variance of the estimate) linear fixed regression of the log OR
            against the inverse of the sample size (linear-regression model) were used to evaluate
            small-study effects [<xref ref-type="bibr" rid="pmed-0030520-b020">20</xref>,<xref ref-type="bibr" rid="pmed-0030520-b021">21</xref>]. To
            evaluate stability over time of the effect estimate, cumulative meta-analysis using
            random effect models was conducted [<xref ref-type="bibr" rid="pmed-0030520-b020">20</xref>].</p>
        </sec>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Case-Control Study</title>
        <p>Clinical and demographic data of the cases and controls are shown in <xref ref-type="table" rid="pmed-0030520-t001">Table 1</xref>. There were no significant
          differences in maternal age, ethnic background, and socioeconomic position between cases
          and controls (<xref ref-type="table" rid="pmed-0030520-t001">Table 1</xref>). Expected
          differences in maternal blood pressure, parity, and newborn weight and condition were
          recorded.</p>
        <table-wrap content-type="2col" id="pmed-0030520-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.0030520.t001</object-id><label>Table 1</label><caption>
            <p>Maternal and Neonatal Characteristics of the Sample Studied</p>
          </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.t001" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb1col1" align="left" charoff="0" char=""/><col id="tb1col2" align="left" charoff="0" char=""/><col id="tb1col3" align="char" charoff="0" char=""/><col id="tb1col4" align="left" charoff="0" char=""/><col id="tb1col5" align="char" charoff="0" char="."/></colgroup><thead><tr><td align="left"><hr/>Category</td><td valign="middle"><hr/>Variable</td><td valign="middle"><hr/>Cases (<italic>n</italic> &equals; 665)</td><td valign="middle"><hr/>Controls (<italic>n</italic> &equals; 1,046)</td><td valign="middle"><hr/><italic>p</italic>-Value</td></tr></thead><tbody><tr><td><bold>Ethnic background</bold></td><td>European descent</td><td>63 (9.5&percnt;)</td><td>141 (13.5&percnt;)</td><td></td></tr><tr><td></td><td>African American</td><td>117 (17.6&percnt;)</td><td>176 (16.3&percnt;)</td><td></td></tr><tr><td></td><td>Native American</td><td>9 (1.4&percnt;)</td><td>11 (1.1&percnt;)</td><td></td></tr><tr><td></td><td>Mixture</td><td>476 (71.6&percnt;)</td><td>718 (68.6&percnt;)</td><td>0.092</td></tr><tr><td><bold>Socioeconomic</bold></td><td>Low socioeconomic status</td><td valign="bottom">585/642 (91.1&percnt;)</td><td valign="bottom">922/1,011 (91.2&percnt;)</td><td valign="bottom">0.958</td></tr><tr><td><bold>Maternal</bold></td><td>Maternal age (y)</td><td valign="bottom">19.0 &plusmn; 2.9</td><td valign="bottom">18.7 &plusmn; 2.6</td><td valign="bottom">0.013</td></tr><tr><td></td><td>Smoking during pregnancy</td><td valign="bottom">11/660 (1.7&percnt;)</td><td valign="bottom">37/1,045 (3.5&percnt;)</td><td valign="bottom">0.023</td></tr><tr><td></td><td>Systolic blood pressure (mm Hg)</td><td valign="bottom">146.1 &plusmn; 12.1</td><td valign="bottom">110.9 &plusmn; 9.2</td><td valign="bottom">&lt; 0.001</td></tr><tr><td></td><td>Diastolic blood pressure (mm Hg)</td><td valign="bottom">96.5 &plusmn; 8.1</td><td valign="bottom">68.1 &plusmn; 7.1</td><td valign="bottom">&lt; 0.001</td></tr><tr><td></td><td>Multiple pregnancy</td><td valign="bottom">19/663 (2.9&percnt;)</td><td valign="bottom">4/1,038 (0.4&percnt;)</td><td valign="bottom">&lt; 0.001</td></tr><tr><td></td><td>Gestational age at delivery (wk)</td><td valign="bottom">37.0 &plusmn; 3.6</td><td valign="bottom">39.2 &plusmn; 1.2</td><td valign="bottom">&lt; 0.001</td></tr><tr><td><bold>Maternal <italic>ACE-I/D</italic> genotype</bold></td><td><italic>DD</italic></td><td>140 (21.1&percnt;)</td><td>230 (22.0&percnt;)</td><td></td></tr><tr><td></td><td><italic>ID</italic></td><td>382 (57.4&percnt;)</td><td>607 (58.0&percnt;)</td><td>0.72</td></tr><tr><td></td><td><italic>II</italic></td><td>143 (21.5&percnt;)</td><td>209 (20.0&percnt;)</td><td></td></tr><tr><td><bold>Allele frequency</bold></td><td><italic>D</italic></td><td>662 (49.8&percnt;)</td><td>1,067 (51.0&percnt;)</td><td></td></tr><tr><td></td><td><italic>I</italic></td><td>668 (50.2&percnt;)</td><td>1,025 (49.0&percnt;)</td><td>0.483</td></tr><tr><td><bold>Newborn characteristics</bold></td><td>Newborn weight (g)</td><td>2,626 &plusmn; 730</td><td>3,126 &plusmn; 434</td><td>&lt; 0.001</td></tr><tr><td></td><td>Newborn height (cm)</td><td>46.9 &plusmn; 4.6</td><td>49.6 &plusmn; 2.4</td><td>&lt; 0.001</td></tr><tr><td></td><td>Low (&lt; 7) Apgar score at first min</td><td>83/671 (12.4&percnt;)</td><td>67/1,025 (6.5&percnt;)</td><td>&lt; 0.001</td></tr><tr><td></td><td>Low (&lt; 7) Apgar score at fifth min</td><td>34/671 (5.1&percnt;)</td><td>5/1,024 (0.5&percnt;)</td><td>&lt; 0.001</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt101"><p>Data are presented as <italic>n</italic> (&percnt;) or mean &plusmn; SD.</p></fn></table-wrap-foot> --></table-wrap>
        <p>The distribution of the <italic>ACE-I/D</italic> genotypes and allelic frequencies were
          not significantly different according to the case-control status (<xref ref-type="table" rid="pmed-0030520-t001">Table 1</xref>). Genotype frequencies according to the ethnic
          group and by recruitment centre are reported in “Appendix Table I” in
            <xref ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>. An
          additive model (per-<italic>D</italic>-allele) revealed a null association between the
            <italic>ACE-I/D</italic> variant and preeclampsia risk (crude OR = 0.95
          [95% CI, 0.81–1.10]). Adjusting for maternal age,
          ethnicity, recruitment centre, and place of birth, aimed to minimize the effect of
          possible population admixture, did not change the estimate of the effect (model-1 OR
          = 0.92 [95% CI, 0.78–1.07]). A similar
          result was obtained after further adjustment for additional potential confounders such as
          socioeconomic position, presence of urinary or vaginal infections during pregnancy, and
          smoking status during pregnancy (model-2 OR = 0.90 [95% CI,
          0.77–1.06]). ORs for other genetic models of inheritance also yielded a
          null association (<xref ref-type="table" rid="pmed-0030520-t002">Table 2</xref>).
          Pre-specified exploratory subgroup analyses indicated that with the exception of family
          history of preeclampsia (positive-history OR = 1.30 [99%
          CI, 0.75–2.26] versus negative-history OR = 0.86
          [99% CI, 0.68–1.10]; <italic>p</italic>-value for
          heterogeneity equal to 0.07), no substantial heterogeneity of the genetic effect size was
          observed for any of the subgroups (<xref ref-type="fig" rid="pmed-0030520-g001">Figure
          1</xref>). Additionally, stratified analysis by recruitment centre according to the
          conformity with Hardy-Weinberg equilibrium yielded similar, null results (see
          “Appendix Table II” in <xref ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>).</p>
        <table-wrap content-type="1col" id="pmed-0030520-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.0030520.t002</object-id><label>Table 2</label><caption>
            <p>Estimate of the Effect of the <italic>ACE-I/D</italic> Polymorphism on Preeclampsia
              Risk Modeled with Logistic Regression</p>
          </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.t002" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb2col1" align="left" charoff="0" char=""/><col id="tb2col2" align="left" charoff="0" char=""/><col id="tb2col3" align="left" charoff="0" char=""/><col id="tb2col4" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left"><hr/>Association</td><td><hr/>Unadjusted OR (95&percnt; CI)</td><td><hr/>Model-1 OR (95&percnt; CI)</td><td><hr/>Model-2 OR (95&percnt; CI)</td></tr></thead><tbody><tr><td>Dominant model (<italic>D</italic>-carriers<sup>a</sup> versus <italic>II</italic>)</td><td>0.91 (0.71&ndash;1.17)</td><td>0.86 (0.67&ndash;1.11)</td><td>0.84 (0.65&ndash;1.09)</td></tr><tr><td>Recessive model (<italic>DD</italic><sup>a</sup> versus <italic>I</italic>-carriers)</td><td>0.95 (0.75&ndash;1.21)</td><td>0.93 (0.72&ndash;1.18)</td><td>0.92 (0.71&ndash;1.18)</td></tr><tr><td>Additive model (per- in increase in <italic>D</italic>-allele<sup>a</sup>)</td><td>0.95 (0.81&ndash;1.10)</td><td>0.92 (0.78&ndash;1.07)</td><td>0.90 (0.77&ndash;1.06)</td></tr><tr><td>Pairwise comparisons, <italic>ID</italic><sup>a</sup> versus <italic>II</italic></td><td>0.83 (0.65&ndash;1.06)</td><td>0.87 (0.67&ndash;1.13)</td><td>0.85 (10.65&ndash;1.12)</td></tr><tr><td>Pairwise comparisons, <italic>DD</italic><sup>a</sup> versus <italic>II</italic></td><td>0.81 (0.60&ndash;1.08)</td><td>0.83 (0.60&ndash;1.16)</td><td>0.82 (0.59&ndash;1.14)</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt201"><p>Model-1: Adjusted by maternal age, ethnicity, recruitment centre, and place of birth. Model-2: Previous variables plus socioeconomic status, infections during pregnancy (urinary or vaginal), and smoking status during pregnancy.</p></fn><fn id="nt202"><p><sup>a</sup>The genotype or allele considered at risk.</p></fn></table-wrap-foot> --></table-wrap>
        <fig id="pmed-0030520-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pmed.0030520.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Risk Association of <italic>ACE-I/D</italic> Variant with Preeclampsia in
              Selected Subgroups within the Current Study</title>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.g001" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s3b">
        <title>Meta-Analysis</title>
        <p>A total of 30 genetic association studies, including the present study, evaluating the
            <italic>ACE-I/D</italic> gene variant and preeclampsia risk were identified
            [<xref ref-type="bibr" rid="pmed-0030520-b017">17</xref>,<xref ref-type="bibr" rid="pmed-0030520-b022">22</xref>–<xref ref-type="bibr" rid="pmed-0030520-b049">49</xref>]. We excluded eight out of 30 studies for one
          or more of the following reasons: two in which duplication or partial overlapping of
          reported data were considered likely [<xref ref-type="bibr" rid="pmed-0030520-b043">43</xref>,<xref ref-type="bibr" rid="pmed-0030520-b044">44</xref>]; three in which the outcome evaluated was solely gestational
          hypertension [<xref ref-type="bibr" rid="pmed-0030520-b045">45</xref>–<xref ref-type="bibr" rid="pmed-0030520-b047">47</xref>];
          one in which relevant data were not reported and could not be obtained from study authors
            [<xref ref-type="bibr" rid="pmed-0030520-b048">48</xref>]; one that
          only recruited women with previous preeclampsia [<xref ref-type="bibr" rid="pmed-0030520-b017">17</xref>]; and one in which the sampling frame was
          based on the <italic>ACE-I/D</italic> genotype [<xref ref-type="bibr" rid="pmed-0030520-b049">49</xref>]. A total of 22 genetic association studies
          including 2,596 cases and 3,828 controls were included in the present meta-analysis (<xref ref-type="table" rid="pmed-0030520-t301">Tables 3</xref> and <xref ref-type="table" rid="pmed-0030520-t004">4</xref>) [<xref ref-type="bibr" rid="pmed-0030520-b022">22</xref>–<xref ref-type="bibr" rid="pmed-0030520-b042">42</xref>]. Out of the 22 studies, nine were conducted
          with Asian participants, eight with participants of European descent, two with African
          Americans, two with more than one ethnic group, and one with South Asians.</p>
        <table-wrap content-type="3col" id="pmed-0030520-t301" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.0030520.t301</object-id><label>Table 3</label><caption>
            <p>Characteristics of Published Studies of the Association between the
              <italic>ACE-I/D</italic> Polymorphism and Preeclampsia Included in the
            Meta-Analysis</p>
          </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.t301" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb3col1" align="left" charoff="0" char=""/><col id="tb3col2" align="left" charoff="0" char=""/><col id="tb3col3" align="char" charoff="0" char="."/><col id="tb3col4" align="char" charoff="0" char="."/><col id="tb3col5" align="char" charoff="0" char="."/><col id="tb3col6" align="char" charoff="0" char="."/><col id="tb3col7" align="char" charoff="0" char="."/><col id="tb3col8" align="char" charoff="0" char="."/><col id="tb3col9" align="char" charoff="0" char="."/><col id="tb3col10" align="char" charoff="0" char="."/><col id="tb3col11" align="char" charoff="0" char="."/><col id="tb3col12" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left"><hr/>Reference</td><td><hr/>Year</td><td><hr/>Total Cases</td><td><hr/>Total Controls</td><td><hr/>Total Sample Size</td><td><hr/><italic>DD</italic> Genotype Cases, <italic>n</italic></td><td><hr/><italic>ID</italic> Genotype Cases, <italic>n</italic></td><td><hr/><italic>II</italic> Genotype Cases, <italic>n</italic></td><td><hr/><italic>DD</italic> Genotype Controls, <italic>n</italic></td><td><hr/><italic>ID</italic> Genotype Controls, <italic>n</italic></td><td><hr/><italic>II</italic> Genotype Controls, <italic>n</italic></td><td><hr/>Design</td></tr></thead><tbody><tr><td>Bai &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b022">22</xref>&rsqb; </td><td>2002</td><td>81</td><td>199</td><td>280</td><td>8</td><td>38</td><td>35</td><td>31</td><td>83</td><td>85</td><td>Case-control</td></tr><tr><td>Bouba &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b023">23</xref>&rsqb; </td><td>2003</td><td>41</td><td>102</td><td>143</td><td>17</td><td>19</td><td>5</td><td>29</td><td>52</td><td>21</td><td>Case-control</td></tr><tr><td>Choi H &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b024">24</xref>&rsqb; </td><td>2004</td><td>90</td><td>98</td><td>188</td><td>33</td><td>34</td><td>23</td><td>14</td><td>51</td><td>33</td><td>Case-control</td></tr><tr><td>Dizon-Townson &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b025">25</xref>&rsqb; </td><td>1995</td><td>124</td><td>200</td><td>324</td><td>49</td><td>42</td><td>33</td><td>65</td><td>98</td><td>37</td><td>Case-control</td></tr><tr><td>Galao &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b026">26</xref>&rsqb; </td><td>2004</td><td>51</td><td>71</td><td>122</td><td>16</td><td>23</td><td>12</td><td>21</td><td>33</td><td>17</td><td>Case-control</td></tr><tr><td>Gurdol &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b027">27</xref>&rsqb; </td><td>2004</td><td>95</td><td>89</td><td>184</td><td>47</td><td>31</td><td>17</td><td>31</td><td>37</td><td>21</td><td>Case-control</td></tr><tr><td>Heiskanen &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b028">28</xref>&rsqb;</td> <td>2001</td><td>133</td><td>115</td><td>248</td><td>43</td><td>59</td><td>31</td><td>31</td><td>58</td><td>26</td><td>Case-control</td></tr><tr><td>Kaur &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b029">29</xref>&rsqb; </td><td>2005</td><td>50</td><td>50</td><td>100</td><td>30</td><td>14</td><td>6</td><td>15</td><td>26</td><td>9</td><td>Case-control</td></tr><tr><td>Kim &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b030">30</xref>&rsqb; </td><td>2004</td><td>98</td><td>110</td><td>208</td><td>26</td><td>36</td><td>36</td><td>25</td><td>52</td><td>33</td><td>Case-control</td></tr><tr><td>Kobashi &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b031">31</xref>&rsqb; </td><td>2005</td><td>122</td><td>291</td><td>413</td><td>19</td><td>52</td><td>51</td><td>35</td><td>136</td><td>120</td><td>Case-control</td></tr><tr><td>Levesque &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b032">32</xref>&rsqb; </td><td>2004</td><td>174</td><td>306</td><td>480</td><td>50</td><td>92</td><td>32</td><td>97</td><td>151</td><td>58</td><td>Nested case-contol</td></tr><tr><td>Mingwei &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b033">33</xref>&rsqb; </td><td>1998</td><td>35</td><td>25</td><td>60</td><td>23</td><td>7</td><td>5</td><td>2</td><td>10</td><td>13</td><td>Case-control</td></tr><tr><td>Morgan &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b034">34</xref>&rsqb; </td><td>1999</td><td>73</td><td>83</td><td>156</td><td>23</td><td>31</td><td>19</td><td>25</td><td>36</td><td>22</td><td>Case-control</td></tr><tr><td>Mozgovaia &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b035">35</xref>&rsqb;</td><td>2000</td><td>45</td><td>73</td><td>118</td><td>21</td><td>14</td><td>10</td><td>28</td><td>37</td><td>8</td><td>Case-control</td></tr><tr><td>Roberts &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b036">36</xref>&rsqb; </td><td>2004</td><td>391</td><td>338</td><td>729</td><td>183</td><td>164</td><td>44</td><td>152</td><td>142</td><td>44</td><td>Case-control</td></tr><tr><td>Roh &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b037">37</xref>&rsqb; </td><td>1997</td><td>36</td><td>115</td><td>151</td><td>4</td><td>11</td><td>21</td><td>14</td><td>62</td><td>39</td><td>Case-control</td></tr><tr><td>Seremak-Mrozikiewicz &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b038">38</xref>&rsqb;</td><td>2000</td><td>25</td><td>110</td><td>135</td><td>16</td><td>7</td><td>2</td><td>34</td><td>61</td><td>15</td><td>Case-control</td></tr><tr><td>Serrano et al. (present study) </td><td>2006</td><td>665</td><td>1046</td><td>1711</td><td>140</td><td>382</td><td>143</td><td>230</td><td>607</td><td>209</td><td>Case-control</td></tr><tr><td>Tamura &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b039">39</xref>&rsqb; </td><td>1996</td><td>12</td><td>179</td><td>191</td><td>3</td><td>6</td><td>3</td><td>63</td><td>82</td><td>34</td><td>Cohort</td></tr><tr><td>Wang &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b040">40</xref>&rsqb; </td><td>2004</td><td>99</td><td>54</td><td>153</td><td>42</td><td>37</td><td>20</td><td>14</td><td>16</td><td>24</td><td>Case-control</td></tr><tr><td>Watanabe &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b041">41</xref>&rsqb; </td><td>2001</td><td>96</td><td>96</td><td>192</td><td>13</td><td>48</td><td>35</td><td>10</td><td>40</td><td>46</td><td>Case-control</td></tr><tr><td>Zhou &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b042">42</xref>&rsqb;</td><td>1999</td><td>60</td><td>78</td><td>138</td><td>39</td><td>12</td><td>9</td><td>8</td><td>32</td><td>38</td><td>Case-control</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt301"><p> <sup>a</sup>Studies on which the reporting of the criteria to define preeclampsia was unclear. Results from these studies were compared against the others in <xref ref-type="fig" rid="pmed-0030520-g003">Figure 3</xref>.</p></fn><fn id="nt302"><p> <sup>b</sup>Definition used from a posterior manuscript from the same authors.</p></fn><fn id="nt303"><p> BP, blood pressure; HWE, Hardy-Weinberg equilibrium.</p></fn></table-wrap-foot> --></table-wrap>
        <table-wrap content-type="3col" id="pmed-0030520-t302" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.0030520.t302</object-id><label>Table 3</label><caption>
            <p>Extended. </p>
          </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.t302" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb3col1a" align="left" charoff="0" char=""/><col id="tb3col2a" align="left" charoff="0" char=""/><col id="tb3col3a" align="left" charoff="0" char=""/><col id="tb3col4a" align="left" charoff="0" char=""/><col id="tb3col5a" align="left" charoff="0" char=""/><col id="tb3col6a" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left"><hr/>Reference</td><td><hr/>Source of Controls</td><td><hr/>Matching Variable</td><td><hr/>Systolic BP Threshold (mm Hg)</td><td><hr/>Diastolic BP Threshold (mm Hg)</td><td><hr/>Proteinuria Threshold</td></tr></thead><tbody><tr><td>Bai &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b022">22</xref>&rsqb; </td><td>Normal pregnant women </td><td>Maternal age</td><td>140</td><td>90</td><td>Not specified</td></tr><tr><td>Bouba &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b023">23</xref>&rsqb; </td><td>Normotensive pregnant women who had undergone at least two pregnancies with no history of preeclampsia</td><td>None</td><td>140</td><td>90</td><td>&gt;300 mg/l in a random specimen or an excretion of &gt;300 mg per 24 h after 20 wk of gestation.</td></tr><tr><td>Choi H &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b024">24</xref>&rsqb; </td><td>Normotensive volunteers randomly recruited from the Obstetric Service at the Samsung Cheil Hospital</td><td>Maternal age</td><td>140</td><td>90</td><td>&gt; 1 g/l (or 2&plus; dipstick) in random urine</td></tr><tr><td>Dizon-Townson &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b025">25</xref>&rsqb; </td><td>Referred to only as &ldquo;controls&rdquo;</td><td>None</td><td>140</td><td>90</td><td>&gt; 500 mg of protein in 24 h or a new 3 dipstick without infection<sup>b</sup></td></tr><tr><td>Galao &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b026">26</xref>&rsqb; </td><td>Normotensive pregnancy under medical assistance </td><td>None</td><td>140</td><td>90</td><td>&gt; 300 mg/24 h</td></tr><tr><td>Gurdol &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b027">27</xref>&rsqb; </td><td>50 participants were complication-free-pregnancies. The remaining 39 women were normotensive with &ge; 2 pregnancies unaffected by preeclampsia</td><td>None</td><td>140</td><td>90</td><td>&gt; 300 mg/l in a 24-h collection</td></tr><tr><td>Heiskanen &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b028">28</xref>&rsqb;</td><td>Women who delivered at Kuopio University Hospital</td><td>None</td><td>140</td><td>90</td><td>&gt; 300 mg of urinary protein in 24 h</td></tr><tr><td>Kaur &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b029">29</xref>&rsqb; </td><td>Normotensive primigravidae who were followed till delivery</td><td>Gestation and maternal age</td><td>140</td><td>90</td><td>&gt; 0.3 g/l</td></tr><tr><td>Kim &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b030">30</xref>&rsqb; </td><td>Randomly selected nulliparous and parous women who were not affected by preeclampsia in the pregnancy progressing to &gt;20 weeks' gestation</td><td>None</td><td>140</td><td>90</td><td>&gt; 300 mg/24 h</td></tr><tr><td>Kobashi &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b031">31</xref>&rsqb; </td><td>Randomly selected from healthy pregnant women</td><td>None</td><td>140</td><td>90</td><td>30 mg/dl (1&plus; on a dipstick) or greater</td></tr><tr><td>Levesque &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b032">32</xref>&rsqb; </td><td>Normotensive nulliparous women attending a tertiary perinatal center</td><td>Maternal age, gestational age, body mass index, and month of the year at delivery.</td><td>Not specified</td><td>90</td><td>&ge; 0.3 g/l in a 24-h or &ge; 1&plus;, using Albustix</td></tr><tr><td>Mingwei &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b033">33</xref>&rsqb; </td><td>Control population </td><td>None</td><td>Not specified</td><td>Not specified</td><td>Not specified</td></tr><tr><td>Morgan &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b034">34</xref>&rsqb; </td><td>Normotensive women recruited during the second half of the pregnancy</td><td>None</td><td>140</td><td>90</td><td>&gt; 300 mg/l in 24 h or &ge; 2&plus; on dipstick in a random urine sample</td></tr><tr><td>Mozgovaia &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b035">35</xref>&rsqb;</td><td>Pregnant women without obvious somatic pathology</td><td>None</td><td>140</td><td>90</td><td>&ge; 0.3 g/l in a 24 h</td></tr><tr><td>Roberts &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b036">36</xref>&rsqb; </td><td>Healthy pregnant normotensive participants who had delivery normally beyond 37th week of gestation</td><td>None</td><td>140</td><td>90</td><td>1&plus; on dipstick after 34 wk of gestation</td></tr><tr><td>Roh &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b037">37</xref>&rsqb; </td><td>Normal population </td><td>None</td><td>140</td><td>90</td><td>&gt; 300 mg/24 h</td></tr><tr><td>Seremak-Mrozikiewicz &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b038">38</xref>&rsqb;</td><td>Healthy pregnant women</td><td>None</td><td>160</td><td>110</td><td>&gt; 5 g in 24 h</td></tr><tr><td>Serrano et al. (present study)</td><td>Healthy normotensive pregnant women at delivery from the same hospitals where cases were recruited</td><td>None</td><td>140</td><td>90</td><td>&gt; 0.3 g in 24 h, or &gt; 2&plus; reading on dipstick in a random sample</td></tr><tr><td>Tamura &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b039">39</xref>&rsqb; </td><td>Pregnant women enrolled in a clinical trial who did not develop preeclampsia or pregnancy induced hypertension</td><td>None</td><td>140</td><td>90</td><td>Referred to as proteinuria (not threshold reported)</td></tr><tr><td>Wang &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b040">40</xref>&rsqb;</td><td>Normal pregnant women</td><td>None</td><td>Not specified</td><td>Not specified</td><td>Not specified</td></tr><tr><td>Watanabe &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b041">41</xref>&rsqb; </td><td>Healthy pregnant volunteers</td><td>Maternal age</td><td>160</td><td>110</td><td>&ge; 5 g in a 24-h collection or &ge; 3&plus; on dipstick testing of two random urine samples collected at least 4 h apart</td></tr><tr><td>Zhou &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b042">42</xref>&rsqb; </td><td>Healthy pregnant women </td><td>None</td><td>Not specified</td><td>Not specified</td><td>Not specified</td></tr></tbody></table> --></table-wrap>
        <table-wrap content-type="3col" id="pmed-0030520-t303" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.0030520.t303</object-id><label>Table 3</label><caption>
            <p>Extended. </p>
          </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.t303" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb3col1b" align="left" charoff="0" char=""/><col id="tb3col2b" align="left" charoff="0" char=""/><col id="tb3col3b" align="left" charoff="0" char=""/><col id="tb3col4b" align="left" charoff="0" char=""/><col id="tb3col5b" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left"><hr/>Reference</td><td><hr/>Reference Cited to Define Preeclampsia </td><td><hr/>Main Exclusion Criteria</td><td><hr/>Country</td><td><hr/>Ethnicity</td></tr></thead><tbody><tr><td>Bai &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b022">22</xref>&rsqb; </td><td>Authors referred only to: &ldquo;rigorous definition of pre-eclampsia&rdquo;<sup>a</sup></td><td>Not specified</td><td>China</td><td>Asian</td></tr><tr><td>Bouba &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b023">23</xref>&rsqb; </td><td>Not specified </td><td>Preexisting cardiovascular or renal disease</td><td>Greece</td><td>European</td></tr><tr><td>Choi H &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b024">24</xref>&rsqb; </td><td>&lsqb;<xref ref-type="bibr" rid="pmed-0030520-b066">66</xref>&rsqb; </td><td>Cardiac disease, serum creatinine &gt; 150 &mu;mol/l or the presence of other systemic disease</td><td>Korea</td><td>Asian</td></tr><tr><td>Dizon-Townson &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b025">25</xref>&rsqb; </td><td>Not specified<sup>a</sup> </td><td>Not specified</td><td>United States</td><td>European</td></tr><tr><td>Galao &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b026">26</xref>&rsqb; </td><td>&lsqb;<xref ref-type="bibr" rid="pmed-0030520-b066">66</xref>&rsqb;</td><td>History of essential or secondary hypertension, multiparous women, diabetes mellitus, renal disease</td><td>Brazil</td><td>Hispanic (European and American Indian)</td></tr><tr><td>Gurdol &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b027">27</xref>&rsqb; </td><td>Not specified </td><td>Preexisting hypertension</td><td>Turkey</td><td>European</td></tr><tr><td>Heiskanen &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b028">28</xref>&rsqb; </td><td>&lsqb;<xref ref-type="bibr" rid="pmed-0030520-b067">67</xref>&rsqb;</td><td>Chronic hypertension and multiple pregnancy</td><td>Finland</td><td>European</td></tr><tr><td>Kaur &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b029">29</xref>&rsqb; </td><td>&lsqb;<xref ref-type="bibr" rid="pmed-0030520-b066">66</xref>&rsqb;</td><td>Chronic hypertension, diabetes mellitus, hyperthyroidism, sarcoidosis, chronic renal disorders, collagen disorders</td><td>India</td><td>South Asian</td></tr><tr><td>Kim &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b030">30</xref>&rsqb; </td><td>&lsqb;<xref ref-type="bibr" rid="pmed-0030520-b066">66</xref>&rsqb; </td><td>No chronic hypertension. No personal or family history of preeclampsia (only for controls)</td><td>Korea</td><td>Asian</td></tr><tr><td>Kobashi &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b031">31</xref>&rsqb; </td><td>&lsqb;<xref ref-type="bibr" rid="pmed-0030520-b068">68</xref>&rsqb;</td><td>Preexisting hypertension, renal disease, diabetes mellitus, amniotic fluid abnormalities, fetal anomalies, multiple pregnancies</td><td>Japan</td><td>Asian</td></tr><tr><td>Levesque &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b032">32</xref>&rsqb; </td><td>&lsqb;<xref ref-type="bibr" rid="pmed-0030520-b069">69</xref>&rsqb; </td><td>Preexisting secondary hypertension, preexisting hypertension with superimposed preeclampsia, multiple pregnancies</td><td>Canada</td><td>European</td></tr><tr><td>Mingwei &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b033">33</xref>&rsqb; </td><td>Reported as standard criteria. The authors cited a Chinese textbook of obstetrics and gynecology.<sup>a</sup></td><td>Not specified</td><td>China</td><td>Asian</td></tr><tr><td>Morgan &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b034">34</xref>&rsqb; </td><td>Not specified</td><td>History of essential hypertension, diabetes mellitus, or chronic renal disease</td><td>United Kingdom</td><td>European</td></tr><tr><td>Mozgovaia &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b035">35</xref>&rsqb;</td><td>Not specified</td><td>Not specified</td><td>Russia</td><td>European</td></tr><tr><td>Roberts &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b036">36</xref>&rsqb; </td><td>Not specified</td><td>History of hypertension in a previous pregnancy (only for controls)</td><td>South Africa</td><td>Afro-Caribbean</td></tr><tr><td>Roh &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b037">37</xref>&rsqb; </td><td>American College of Obstetrics and Gynecology</td><td>Not specified</td><td>Korea</td><td>Asian</td></tr><tr><td>Seremak-Mrozikiewicz &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b038">38</xref>&rsqb;</td><td>Not specified</td><td>Multiparous women</td><td>Poland</td><td>European</td></tr><tr><td>Serrano et al. (present study) </td><td>&lsqb;<xref ref-type="bibr" rid="pmed-0030520-b067">67</xref>&rsqb;</td><td>See <xref ref-type="sec" rid="st2">methods</xref> section, manuscript</td><td>Colombia</td><td>Mixed (European, Hispanic, Afro-Caribbean, and Native American)</td></tr><tr><td>Tamura &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b039">39</xref>&rsqb; </td><td>Not specified</td><td>Hypertension, renal disease, diabetes, or other significant medical complications, such as heart disease</td><td>United States</td><td>Afro-Caribbean</td></tr><tr><td>Wang &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b040">40</xref>&rsqb; </td><td>Not specified &dagger;</td><td>Not specified</td><td>China</td><td>Asian</td></tr><tr><td>Watanabe &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b041">41</xref>&rsqb; </td><td>&lsqb;71&rsqb; </td><td>History of hypertension or renal disease</td><td>Japan</td><td>Asian</td></tr><tr><td>Zhou &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b042">42</xref>&rsqb;</td><td>Reported as standard criteria. The authors cited a Chinese textbook of obstetrics and gynaecology</td><td>Not specified</td><td>China</td><td>Asian</td></tr></tbody></table> --></table-wrap>
        <table-wrap content-type="2col" id="pmed-0030520-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.0030520.t004</object-id><label>Table 4</label><caption>
            <p>Characteristics of Published Studies of the Association between the
              <italic>ACE-I/D</italic> Polymorphism and Preeclampsia Included in the
            Meta-Analysis</p>
          </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.t004" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb4col1" align="left" charoff="0" char=""/><col id="tb4col2" align="char" charoff="0" char=""/><col id="tb4col3" align="char" charoff="0" char=""/><col id="tb4col4" align="char" charoff="0" char=""/><col id="tb4col5" align="char" charoff="0" char=""/><col id="tb4col6" align="char" charoff="0" char=""/><col id="tb4col7" align="char" charoff="0" char=""/><col id="tb4col8" align="left" charoff="0" char=""/><col id="tb4col9" align="left" charoff="0" char=""/><col id="tb4col10" align="left" charoff="0" char=""/><col id="tb4col11" align="left" charoff="0" char=""/><col id="tb4col12" align="char" charoff="0" char="."/><col id="tb4col13" align="char" charoff="0" char="."/></colgroup><thead><tr><td align="left"><hr/>Study</td><td><hr/>Mean Maternal Age, Participants</td><td><hr/>Mean Maternal Age, Controls</td><td><hr/>Percentage of Nulliparous Cases</td><td><hr/>Percentage of Nulliparous Controls</td><td><hr/>Gestational Age, Cases</td><td><hr/>Gestational Age, Controls</td><td><hr/>Language of Publication</td><td><hr/>Blinding</td><td><hr/>Confirmation of <italic>DD</italic> Genotype</td><td><hr/>Regenotyping of a Random Subsample</td><td><hr/><italic>&chi;</italic><sup>2</sup> Value for HWE</td><td><hr/>Evidence for Departure from HWE (<italic>p</italic>-Value)</td></tr></thead><tbody><tr><td>Bai &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b022">22</xref>&rsqb;</td><td>28</td><td>28</td><td align="left">Not specified</td><td align="left">Not specified</td><td>Not specified</td><td>Not specified</td><td>Non-English</td><td>Unknown</td><td>Not reported</td><td>Not reported</td><td>1.971</td><td>0.160</td></tr><tr><td>Bouba &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b023">23</xref>&rsqb;</td><td>31</td><td>29</td><td align="left">Not specified</td><td>0</td><td>34.32</td><td>38.96</td><td>English</td><td>Yes</td><td>Yes</td><td>Not reported</td><td>0.069</td><td>0.793</td></tr><tr><td>Choi &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b024">24</xref>&rsqb;</td><td>30</td><td>31</td><td>69</td><td>67</td><td>36.2</td><td>39.7</td><td>English</td><td>Yes</td><td>Yes</td><td>Not reported</td><td>0.650</td><td>0.420</td></tr><tr><td>Dizon-Townson &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b025">25</xref>&rsqb;</td><td>Not specified</td><td>Not specified</td><td align="left">Not specified</td><td align="left">Not specified</td><td>Not specified</td><td>Not specified</td><td>English</td><td>Unknown</td><td>Yes</td><td>Not reported</td><td>&lt; 0.0001</td><td>0.995</td></tr><tr><td>Galao &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b026">26</xref>&rsqb;</td><td>21</td><td>25</td><td>100</td><td align="left">Not specified</td><td>36.2</td><td>39</td><td>English</td><td>No</td><td>Yes</td><td>Not reported</td><td>0.323</td><td>0.569</td></tr><tr><td>Gurdol &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b027">27</xref>&rsqb;</td><td>28</td><td>27</td><td align="left">Not specified</td><td>56</td><td>30&ndash;38</td><td>30&ndash;38</td><td>English</td><td>Yes</td><td>Yes</td><td>Not reported</td><td>2.219</td><td>0.136</td></tr><tr><td>Heiskanen &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b028">28</xref>&rsqb;</td><td>Not specified</td><td>Not specified</td><td align="left">Not specified</td><td align="left">Not specified</td><td>Not specified</td><td>Not specified</td><td>English</td><td>Yes</td><td>Not reported</td><td>Not reported</td><td>0.013</td><td>0.909</td></tr><tr><td>Kaur &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b029">29</xref>&rsqb;</td><td>25</td><td>24</td><td>100</td><td>100</td><td>35.9</td><td>35.8</td><td>English</td><td>Yes</td><td>Not reported</td><td>Not reported</td><td>0.152</td><td>0.696</td></tr><tr><td>Kim &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b030">30</xref>&rsqb;</td><td>31</td><td>31</td><td>58.6</td><td>48.2</td><td>36.2</td><td>39</td><td>English</td><td>Yes</td><td>Not reported</td><td>Not reported</td><td>0.270</td><td>0.603</td></tr><tr><td>Kobashi &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b031">31</xref>&rsqb;</td><td>29</td><td>29</td><td>70</td><td>57</td><td>36.4</td><td>39.1</td><td>English</td><td>Unknown</td><td>Yes</td><td>Not reported</td><td>0.140</td><td>0.708</td></tr><tr><td>Levesque &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b032">32</xref>&rsqb;</td><td>26</td><td>26</td><td>100</td><td>100</td><td>36.7</td><td>37.8</td><td>English</td><td>Yes</td><td>Yes</td><td>Not reported</td><td>0.003</td><td>0.955</td></tr><tr><td>Mingwei &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b033">33</xref>&rsqb;</td><td>Not specified</td><td>Not specified</td><td>100</td><td align="left">Not specified</td><td>Not specified</td><td>Not specified</td><td>Non-English</td><td>Unknown</td><td>Not reported</td><td>Not reported</td><td>0.002</td><td>0.968</td></tr><tr><td>Morgan &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b034">34</xref>&rsqb;</td><td>29</td><td>28</td><td>84.7</td><td>90</td><td>35.5</td><td>39.9</td><td>English</td><td>Yes</td><td>Yes</td><td>Not reported</td><td>1.433</td><td>0.231</td></tr><tr><td>Mozgovaia &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b035">35</xref>&rsqb;</td><td>Not specified</td><td>Not specified</td><td align="left">Not specified</td><td align="left">Not specified</td><td>Not specified</td><td>Not specified</td><td>English</td><td>Yes</td><td>Not reported</td><td>Not reported</td><td>0.672</td><td>0.412</td></tr><tr><td>Roberts &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b036">36</xref>&rsqb;</td><td>26</td><td>25</td><td>0</td><td>0</td><td>34.4</td><td>38.8</td><td>English</td><td>No</td><td>Yes</td><td>Not reported</td><td>1.394</td><td>0.237</td></tr><tr><td>Roh &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b037">37</xref>&rsqb;</td><td>Not specified</td><td>Not specified</td><td align="left">Not specified</td><td align="left">Not specified</td><td>Not specified</td><td>Not specified</td><td>Non-English</td><td>Unknown</td><td>Not reported</td><td>Not reported</td><td>1.990</td><td>0.157</td></tr><tr><td>Seremak- Mrozikiewicz &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b038">38</xref>&rsqb;</td><td>25.2</td><td>25.6</td><td>100</td><td align="left">Not specified</td><td>36</td><td>38.1</td><td>English</td><td>Yes</td><td>Not reported</td><td>Not reported</td><td>2.256</td><td>0.133</td></tr><tr><td>Serrano et al. (present study)</td><td>19</td><td>18</td><td>100</td><td>100</td><td>37</td><td>39</td><td>English</td><td>Yes</td><td>Yes</td><td>Yes</td><td>27.140</td><td>&lt; 0.00001</td></tr><tr><td>Tamura &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b039">39</xref>&rsqb;</td><td>23</td><td>23</td><td align="left">Not specified</td><td>53</td><td>Not specified</td><td>38</td><td>English</td><td>Yes</td><td>Yes</td><td>Not reported</td><td>0.625</td><td>0.429</td></tr><tr><td>Wang &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b040">40</xref>&rsqb;</td><td>Not specified</td><td>Not specified</td><td align="left">Not specified</td><td align="left">Not specified</td><td>Not specified</td><td>Not specified</td><td>Non-English</td><td>Unknown</td><td>Not reported</td><td>Not reported</td><td>8.061</td><td>0.004</td></tr><tr><td>Watanabe &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b041">41</xref>&rsqb;</td><td>Not specified</td><td>Not specified</td><td align="left">Not specified</td><td align="left">Not specified</td><td>Not specified</td><td>Not specified</td><td>English</td><td>No</td><td>Not reported</td><td>Not reported</td><td>0.088</td><td>0.766</td></tr><tr><td>Zhou &lsqb;<xref ref-type="bibr" rid="pmed-0030520-b042">42</xref>&rsqb;</td><td>Not specified</td><td>Not specified</td><td>100</td><td>100</td><td>Not specified</td><td>Not specified</td><td>Non-English</td><td>Unknown</td><td>Yes</td><td>Not reported</td><td>0.107</td><td>0.743</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt401"><p>&ldquo;Blinding&rdquo; column indicates whether laboratory staff was blind or not to the case-control status. All samples were genotyped by PCR.</p></fn><fn id="nt402"><p>HWE, Hardy-Weinberg equilibrium.</p></fn></table-wrap-foot> --></table-wrap>
        <fig id="pmed-0030520-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pmed.0030520.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Meta-Analysis of Studies of <italic>ACE-I/D</italic> Polymorphism and Risk of
              Preeclampsia</title>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.g002" xlink:type="simple"/>
        </fig>
        <fig id="pmed-0030520-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pmed.0030520.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Studies of <italic>ACE-I/D</italic> Polymorphism and Risk of Preeclampsia Grouped
              by Study Characteristics</title>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.g003" xlink:type="simple"/>
        </fig>
        <p>The OR under an additive model for preeclampsia was 1.26 (95% CI,
          1.07–1.49; <italic>p</italic> = 0.006) (<xref ref-type="fig" rid="pmed-0030520-g002">Figure 2</xref>). However, there was evidence of substantial
          between-study heterogeneity (<italic>I</italic><sup>2</sup> = 75.1%,
              <italic>χ<sub>21</sub></italic><sup>2</sup> = 84.23,
            <italic>p</italic><sub>Het</sub> &lt; 0.0001). Study characteristics such as
          blinding of genotyping staff, publication language, preeclampsia definition, and disease
          severity explained little of the heterogeneity (<xref ref-type="fig" rid="pmed-0030520-g003">Figure 3</xref>). A stratified analysis by study size, evaluated
          as the number of cases in each study (&lt;100, 100–200, and ≥200),
          showed a diminished effect as the study size increased
            (<italic>χ<sub>2</sub></italic><sup>2</sup> = 16.95,
            <italic>p</italic><sub>Het</sub> = 0.0002) (<xref ref-type="fig" rid="pmed-0030520-g003">Figure 3</xref>). Analogous results were obtained when different
          cutoff points (&lt; 100, 100–500, and ≥ 500) for the number of cases
          were used (<italic>χ<sub>2</sub></italic><sup>2</sup> = 18.51,
            <italic>p</italic><sub>Het</sub> = 0.00009). Similarly, stratifying by
          ethnicity indicated that studies conducted in Asian populations tended to have a larger
          ORs (<italic>χ<sub>5</sub></italic><sup>2</sup> = 14.4,
            <italic>p</italic><sub>Het</sub> = 0.007). These findings might be explained
          by the fact that eight out of the nine studies conducted in Asian populations had fewer
          than 100 cases in each study. The funnel plot including all studies was asymmetric, and
          the Egger's test (<italic>p</italic> = 0.06) and the linear regression model
            (<italic>p</italic> = 0.003) suggested the presence of an excess of small
          studies with more positive results, predominately of studies published in
          non-English–language journals (<xref ref-type="supplementary-material" rid="pmed-0030520-sg001">Figure S1</xref>; see <xref ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref> for details). A cumulative synthesis of
          ACE-I/D variants and preeclampsia revealed substantial instability of the genetic effect
          over time, with studies published between 1996 and 1997 demonstrating the most protective
          effect, immediately followed by studies published in 1998 and 1999 indicating the most
          significant results in the opposite direction. Then, the effect size is seen to attenuate
          gradually over time toward a null association with the accumulation of more data (<xref ref-type="supplementary-material" rid="pmed-0030520-sg002">Figure S2</xref>; see <xref ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref> for
          details). Genotypic ORs under other genetic models of inheritance are outlined in <xref ref-type="table" rid="pmed-0030520-t005">Table 5</xref>.</p>
        <table-wrap content-type="1col" id="pmed-0030520-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.0030520.t005</object-id><label>Table 5</label><caption>
            <p>Genotypic ORs for Preeclampsia and the <italic>ACE-I/D</italic> Variant.</p>
          </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.t005" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb5col1" align="left" charoff="0" char=""/><col id="tb5col2" align="left" charoff="0" char=""/><col id="tb5col3" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left"><hr/>Model</td><td><hr/>Comparison</td><td><hr/>ACE-I/D Variant</td></tr></thead><tbody><tr><td><bold>Additive model</bold></td><td>Random, OR (95&percnt; CI), <italic>p</italic>-value</td><td>1.26 (1.07&ndash;1.49), <italic>p</italic> &equals; 0.006</td></tr><tr><td></td><td><italic>I</italic><sup>2</sup> (<italic>p</italic> for heterogeneity)</td><td>75.1&percnt; (<italic>p</italic> &lt; 0.0001)</td></tr><tr><td></td><td>Egger test, <italic>p</italic>-value</td><td><italic>p</italic> &equals; 0.06</td></tr><tr><td><bold>Homozygous for rare allele versus homozygous for common allele</bold></td><td>Random, OR (95&percnt; CI), <italic>p</italic>-value</td><td>1.51 (1.09&ndash;2.08), <italic>p</italic> &equals; 0.01</td></tr><tr><td></td><td><italic>I</italic><sup>2</sup> (<italic>p</italic> for heterogeneity)</td><td>71.8&percnt; (<italic>p</italic> &lt; 0.0001)</td></tr><tr><td></td><td>Egger test, <italic>p</italic>-value</td><td><italic>p</italic> &equals; 0.02</td></tr><tr><td><bold>Heterozygous versus homozygous for common allele</bold></td><td>Random, OR (95&percnt; CI), <italic>p</italic>-value</td><td>0.94 (0.78&ndash;1.12), <italic>p</italic> &equals; 0.50</td></tr><tr><td></td><td><italic>I</italic><sup>2</sup> (<italic>p</italic> for heterogeneity)</td><td>31.5&percnt; (<italic>p</italic> &equals; 0.07)</td></tr><tr><td></td><td>Egger test, <italic>p</italic>-value</td><td><italic>p</italic> &equals; 0.76</td></tr><tr><td><bold>Recessive model</bold></td><td>Random, OR (95&percnt; CI), <italic>p</italic>-value</td><td>1.59 (1.22&ndash;2.07), <italic>p</italic> &equals; 0.001</td></tr><tr><td></td><td><italic>I</italic><sup>2</sup> (<italic>p</italic> for heterogeneity)</td><td>74.5&percnt; (<italic>p</italic> &lt; 0.0001)</td></tr><tr><td></td><td>Egger test, <italic>p</italic>-value</td><td><italic>p</italic> &equals;0.008</td></tr><tr><td><bold>Dominant model</bold></td><td>Random, OR (95&percnt; CI), <italic>p</italic>-value</td><td>1.15 (0.91&ndash;1.45), <italic>p</italic> &equals; 0.21</td></tr><tr><td></td><td><italic>I</italic><sup>2</sup> (<italic>p</italic> for heterogeneity)</td><td>63.1&percnt; (<italic>p</italic> &lt; 0.0001)</td></tr><tr><td></td><td>Egger test, <italic>p</italic>-value</td><td><italic>p</italic> &equals; 0.09</td></tr></tbody></table> --><!-- --></table-wrap>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>The current meta-analysis, which includes new data from the largest case-control study to
        date, represents the most comprehensive evaluation of the <italic>ACE-I/D</italic> variant
        in preeclampsia. Although a pooled per-allele OR suggested evidence of an increase in the
        risk of preeclampsia of 1.26 (95% CI, 1.07–1.49), the robustness of
        this summary estimate is uncertain. First, our study found a null association of the
          <italic>ACE-I/D</italic> variant with preeclampsia. Moreover, there was no substantial
        evidence of a positive effect in any of the subgroups in the prespecified analyses. Second,
        the meta-analysis revealed diminishing summary risk estimate as study size increased (<xref ref-type="fig" rid="pmed-0030520-g003">Figure 3</xref>), regardless of the arbitrary
        cutoff points used to define the categories. This result is concordant with the results of
        several statistical tests used to evaluate the presence of small-study bias (Egger's test
          <italic>p</italic> = 0.06 and linear-regression model test <italic>p</italic>
        = 0.003). Furthermore, since only the published literature was included, it is
        possible that including unpublished studies (which more often provide evidence of negative
        or null effects) would have provided additional evidence of small-study bias. Taken
        together, these findings point to small-study bias as a potential explanation for the
        results observed in the meta-analysis. Discrepant findings from large and small studies are
        not new in the field of genetics of complex disorders [<xref ref-type="bibr" rid="pmed-0030520-b050">50</xref>]. When present, discrepancy of genetic effects
        sizes may be due to multiple causes such as genuine heterogeneity, data manipulation and
        fabrication, study quality, or publication bias. A form of publication bias relevant to the
        current report is within-study reporting bias. Because of the facility of measuring multiple
        genetic markers in a study, significant positive and negative associations (sometimes
        arising from multiple testing) are more likely to be published early rather than late.
        Results from the cumulative meta-analysis support this as one possible explanation, which
        has been referred to as the Proteus phenomenon [<xref ref-type="bibr" rid="pmed-0030520-b051">51</xref>]. Further evidence in support of the presence
        of within-study reporting bias is the fact that studies published in languages other than
        English, and in the Asian ethnic group, tend to have larger effects, findings consistent
        with other recent results [<xref ref-type="bibr" rid="pmed-0030520-b052">52</xref>].</p>
      <p>Publication bias is increasingly being recognized as one of the main threats to the
        reliability of conclusions drawn from association studies with common disease outcomes. In
        the setting of cardiovascular and neurological diseases, several positive
        gene–disease associations, usually based on meta-analysis of small studies, have
        been subsequently refuted by large genetic studies [<xref ref-type="bibr" rid="pmed-0030520-b013">13</xref>,<xref ref-type="bibr" rid="pmed-0030520-b053">53</xref>]. As a result, several initiatives are now underway to help overcome
        problems of reporting and publication bias and to help to achieve datasets of appropriate
        size to detect plausible genetic effects for common disorders, which are likely to require
        several thousands of cases of the disease (The Wellcome Trust Case Control Consortium,
          <ext-link ext-link-type="uri" xlink:href="http://www.wtccc.org.uk" xlink:type="simple">http://www.wtccc.org.uk</ext-link>) [<xref ref-type="bibr" rid="pmed-0030520-b054">54</xref>]. Genetic studies in preeclampsia continue to be somewhat small in
        size [<xref ref-type="bibr" rid="pmed-0030520-b055">55</xref>,<xref ref-type="bibr" rid="pmed-0030520-b056">56</xref>] and are usually underpowered to detect
        realistic genotypic relative risks (ORs between 1.15 and 1.4) [<xref ref-type="bibr" rid="pmed-0030520-b014">14</xref>,<xref ref-type="bibr" rid="pmed-0030520-b057">57</xref>]. However, considering the low incidence of
        preeclampsia (2%–3% in developed countries), it is highly
        unlikely that a single centre will be able to amass the large number of cases required, and
        the development of networks of interested investigators may be essential [<xref ref-type="bibr" rid="pmed-0030520-b054">54</xref>]. Therefore, international
        collaborations, particularly among those countries with a high incidence of preeclampsia,
        may make recruitment more efficient and help to include participants with different cultural
        and genetic backgrounds, which can provide further insight into the aetiology of the disease
        both genetic and/or environmental.</p>
      <p>Despite these obstacles, the investment in adequate resources to study the genetics of
        preeclampsia is an important priority. Observational studies and the randomised trials of
        interventions that have followed have been unsuccessful thus far in identifying causal
        pathways in preeclampsia amenable to preventive therapies, a clear example of which are the
        recently failed clinical trials using either antioxidant vitamins or calcium supplements
          [<xref ref-type="bibr" rid="pmed-0030520-b058">58</xref>–<xref ref-type="bibr" rid="pmed-0030520-b061">61</xref>]. A genetic approach that is
        less prone to confounding and reverse causation than nongenetic observational studies, may
        be more likely to identify causal pathways and may help to prioritise therapeutic targets
        that require evaluation in large and expensive randomised clinical trials [<xref ref-type="bibr" rid="pmed-0030520-b062">62</xref>,<xref ref-type="bibr" rid="pmed-0030520-b063">63</xref>]. The challenge is in how to make better use of
        the genetic approach in complex diseases such as preeclampsia, in particular to overcome
        random errors in risk estimates from small studies as well as publication bias. A suggested
        approach is to establish a collaborating consortium of investigators from existing studies
        in genetics of preeclampsia to reduce the multiple existing problems such as: (1) inadequate
        selection of candidate gene variants to be evaluated, (2) biased analyses, and selective
        reporting of positive results; (3) to promote access to unpublished data; (4) to overcome
        inadequate outcome definitions; and (5) to provide guidance for developing new large studies
          [<xref ref-type="bibr" rid="pmed-0030520-b054">54</xref>]. Until such
        measures are established, it will be important for both authors and journal editors to
        embrace the publication of both positive and negative results from “well-designed
        case-control” studies to diminish the problem of publication bias [<xref ref-type="bibr" rid="pmed-0030520-b064">64</xref>]. This approach has recently
        become a reality for clinical trials [<xref ref-type="bibr" rid="pmed-0030520-b065">65</xref>], and it might help in reducing the temptation of researchers to
        explore multiple hypotheses in subgroup analyses to obtain one finding of nominal
        statistical significance that might help acceptance of the paper.</p>
      <p>Investigating the aetiology of preeclampsia, one of the main causes of maternal and
        neonatal mortality and morbidity worldwide, should be a health research priority. A genetic
        approach may indeed be useful, but large collaborative studies will also be needed.</p>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="pmed-0030520-sg001" mimetype="application/mspowerpoint" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.sg001" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <title>Funnel Plot of Studies of <italic>ACE-I/D</italic> Polymorphism and Preeclampsia</title>
          <p>ORs for outcome using a per-allele model. Studies in bold are those published in
            non-English-language journals.</p>
          <p>(38 KB PPT)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pmed-0030520-sg002" mimetype="application/mspowerpoint" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.sg002" xlink:type="simple">
        <label>Figure S2</label>
        <caption>
          <title>Cumulative Synthesis of Studies of <italic>ACE-I/D</italic> Polymorphism and
            Preeclampsia</title>
          <p>OR (random effect model) for outcome using a per-allele model.</p>
          <p>(36 KB PPT)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pmed-0030520-sd001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.sd001" xlink:type="simple">
        <label>Protocol S1</label>
        <caption>
          <title><italic>ACE-I/D</italic> Polymorphism and Preeclampsia Risk: Evidence of
            Small-Study Bias</title>
          <p>(68 KB DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pmed-0030520-sd002" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.sd002" xlink:type="simple">
        <label>Alternative Language Abstract S1</label>
        <caption>
          <title>Translation of the Abstract into Spanish</title>
          <p>Translation by N. C. Serrano, Universidad Autónoma de Bucaramanga,
            Bucaramanga, Colombia.</p>
          <p>(25 KB DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pmed-0030520-sd003" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030520.sd003" xlink:type="simple">
        <label>Alternative Language Abstract S2</label>
        <caption>
          <title>Translation of the Abstract into Chinese</title>
          <p>Translation by D. Wang, Medical Statistics Unit, London School of Hygiene and Tropical
            Medicine, London, United Kingdom.</p>
          <p>(33 KB DOC)</p>
        </caption>
      </supplementary-material>
      <sec id="s5a">
        <title>Accession Numbers</title>
        <p>The SNP database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/" xlink:type="simple">http://www.ncbi.nlm.nih.gov/SNP/</ext-link>) single-nucleotide polymorphism discussed in
          this paper is an insertion/deletion variant (rs1799752) referenced to the
          <italic>ACE</italic> gene with the GenBank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Genbank/" xlink:type="simple">http://www.ncbi.nlm.nih.gov/Genbank/</ext-link>) accession number J04144.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>Thanks to Drs Hideki Watanabe, Linda Morgan, Ioannis Georgiou, Rosanna Abate, Jeong Bae
        Park, François Rousseau, Figen Gurdol, Young Ju Kim, Huai Bai, Tsunenobu Tamura,
        Vanita Jain, Agnieszka Seremak-Mrozikiewicz, Vladislav S. Baranov, Adriani Oliveira
        Galão, and Rosemary Pegoraro, who kindly provided additional valuable information
        from their studies to the meta-analyses.</p>
    </ack>
    
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ACE</term>
          <def>
            <p>angiotensin-converting enzyme</p>
          </def>
        </def-item>
        <def-item>
          <term>
            <italic>ACE-I/D</italic>
          </term>
          <def>
            <p>angiotensin- converting enzyme gene</p>
          </def>
        </def-item>
        <def-item>
          <term>CI</term>
          <def>
            <p>confidence interval</p>
          </def>
        </def-item>
        <def-item>
          <term>OR</term>
          <def>
            <p>odds ratio</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <title>References</title>
      <ref id="pmed-0030520-b001">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <collab xlink:type="simple">World Health Organization International Collaborative Study of Hypertensive
            Disorders of Pregnancy</collab>
          <year>1988</year>
          <article-title>Geographic variation in the incidence of hypertension in pregnancy.</article-title>
          <source>Am J Obstet Gynecol</source>
          <volume>158</volume>
          <fpage>80</fpage>
          <lpage>83</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b002">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Khan</surname>
              <given-names>KS</given-names>
            </name>
            <name name-style="western">
              <surname>Wojdyla</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Say</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Gulmezoglu</surname>
              <given-names>AM</given-names>
            </name>
            <name name-style="western">
              <surname>Van Look</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <article-title>WHO analysis of causes of maternal death: A systematic review.</article-title>
          <source>Lancet</source>
          <volume>367</volume>
          <fpage>1066</fpage>
          <lpage>1074</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b003">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sibai</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Dekker</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Kupferminc</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Pre-eclampsia.</article-title>
          <source>Lancet</source>
          <volume>365</volume>
          <fpage>785</fpage>
          <lpage>799</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b004">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Villar</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Abalos</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Nardin</surname>
              <given-names>JM</given-names>
            </name>
            <name name-style="western">
              <surname>Merialdi</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Carroli</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Strategies to prevent and treat preeclampsia: Evidence from randomized
            controlled trials.</article-title>
          <source>Semin Nephrol</source>
          <volume>24</volume>
          <fpage>607</fpage>
          <lpage>615</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b005">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Duckitt</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Harrington</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Risk factors for pre-eclampsia at antenatal booking: Systematic review of
            controlled studies.</article-title>
          <source>BMJ</source>
          <volume>330</volume>
          <fpage>565</fpage>
          <lpage>567</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b006">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ray</surname>
              <given-names>JG</given-names>
            </name>
            <name name-style="western">
              <surname>Vermeulen</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Schull</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Redelmeier</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Cardiovascular health after maternal placental syndromes (CHAMPS):
            Population-based retrospective cohort study.</article-title>
          <source>Lancet</source>
          <volume>366</volume>
          <fpage>1797</fpage>
          <lpage>1803</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b007">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Zaman</surname>
              <given-names>MA</given-names>
            </name>
            <name name-style="western">
              <surname>Oparil</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Calhoun</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <year>2002</year>
          <article-title>Drugs targeting the renin-angiotensin-aldosterone system.</article-title>
          <source>Nat Rev Drug Discov</source>
          <volume>1</volume>
          <fpage>621</fpage>
          <lpage>636</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b008">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Shah</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <article-title>The role of RAS in the pathogenesis of preeclampsia.</article-title>
          <source>Curr Hypertens Rep</source>
          <volume>8</volume>
          <fpage>144</fpage>
          <lpage>152</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b009">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rigat</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Hubert</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Alhenc-Gelas</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Cambien</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Corvol</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1990</year>
          <article-title>An insertion/deletion polymorphism in the angiotensin I-converting enzyme
            gene accounting for half the variance of serum enzyme levels.</article-title>
          <source>J Clin Invest</source>
          <volume>86</volume>
          <fpage>1343</fpage>
          <lpage>1346</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b010">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Agerholm-Larsen</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Nordestgaard</surname>
              <given-names>BG</given-names>
            </name>
            <name name-style="western">
              <surname>Tybjaerg-Hansen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>2000</year>
          <article-title>ACE gene polymorphism in cardiovascular disease: Meta-analyses of small and
            large studies in whites.</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <volume>20</volume>
          <fpage>484</fpage>
          <lpage>492</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b011">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kammerer</surname>
              <given-names>CM</given-names>
            </name>
            <name name-style="western">
              <surname>Gouin</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Samollow</surname>
              <given-names>PB</given-names>
            </name>
            <name name-style="western">
              <surname>VandeBerg</surname>
              <given-names>JF</given-names>
            </name>
            <name name-style="western">
              <surname>Hixson</surname>
              <given-names>JE</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2004</year>
          <article-title>Two quantitative trait loci affect ACE activities in Mexican-Americans.</article-title>
          <source>Hypertension</source>
          <volume>43</volume>
          <fpage>466</fpage>
          <lpage>470</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b012">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sayed-Tabatabaei</surname>
              <given-names>FA</given-names>
            </name>
            <name name-style="western">
              <surname>Houwing-Duistermaat</surname>
              <given-names>JJ</given-names>
            </name>
            <name name-style="western">
              <surname>van Duijn</surname>
              <given-names>CM</given-names>
            </name>
            <name name-style="western">
              <surname>Witteman</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <year>2003</year>
          <article-title>Angiotensin-converting enzyme gene polymorphism and carotid artery wall
            thickness: A meta-analysis.</article-title>
          <source>Stroke</source>
          <volume>34</volume>
          <fpage>1634</fpage>
          <lpage>1639</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b013">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Keavney</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>McKenzie</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Parish</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Palmer</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Clark</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2000</year>
          <article-title>Large-scale test of hypothesised associations between the
            angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction
            in about 5,000 cases and 6,000 controls. International Studies of Infarct Survival
            (ISIS) Collaborators.</article-title>
          <source>Lancet</source>
          <volume>355</volume>
          <fpage>434</fpage>
          <lpage>442</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b014">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Casas</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Hingorani</surname>
              <given-names>AD</given-names>
            </name>
            <name name-style="western">
              <surname>Bautista</surname>
              <given-names>LE</given-names>
            </name>
            <name name-style="western">
              <surname>Sharma</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes
            involving approximately 18,000 cases and 58,000 controls.</article-title>
          <source>Arch Neurol</source>
          <volume>61</volume>
          <fpage>1652</fpage>
          <lpage>1661</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b015">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bonnici</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Keavney</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Collins</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Danesh</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <year>2002</year>
          <article-title>Angiotensin converting enzyme insertion or deletion polymorphism and
            coronary restenosis: Meta-analysis of 16 studies.</article-title>
          <source>BMJ</source>
          <volume>325</volume>
          <fpage>517</fpage>
          <lpage>520</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b016">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ng</surname>
              <given-names>DP</given-names>
            </name>
            <name name-style="western">
              <surname>Tai</surname>
              <given-names>BC</given-names>
            </name>
            <name name-style="western">
              <surname>Koh</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Tan</surname>
              <given-names>KW</given-names>
            </name>
            <name name-style="western">
              <surname>Chia</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Angiotensin-I converting enzyme insertion/deletion polymorphism and its
            association with diabetic nephropathy: A meta-analysis of studies reported between 1994
            and 2004 and comprising 14,727 subjects.</article-title>
          <source>Diabetologia</source>
          <volume>48</volume>
          <fpage>1008</fpage>
          <lpage>1016</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b017">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mello</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Parretti</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Gensini</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Sticchi</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Mecacci</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2003</year>
          <article-title>Maternal-fetal flow, negative events, and preeclampsia: Role of ACE I/D
            polymorphism.</article-title>
          <source>Hypertension</source>
          <volume>41</volume>
          <fpage>932</fpage>
          <lpage>937</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b018">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <collab xlink:type="simple">Report of the National High Blood Pressure Education Program</collab>
          <year>2000</year>
          <article-title>Working Group on High Blood Pressure in Pregnancy.</article-title>
          <source>Am J Obstet Gynecol</source>
          <volume>183</volume>
          <fpage>S1</fpage>
          <lpage>S22</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b019">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Shanmugam</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Sell</surname>
              <given-names>KW</given-names>
            </name>
            <name name-style="western">
              <surname>Saha</surname>
              <given-names>BK</given-names>
            </name>
          </person-group>
          <year>1993</year>
          <article-title>Mistyping ACE heterozygotes.</article-title>
          <source>PCR Methods Appl</source>
          <volume>3</volume>
          <fpage>120</fpage>
          <lpage>121</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b020">
        <label>20</label>
        <element-citation publication-type="other" xlink:type="simple">
          <person-group person-group-type="editor">
            <name name-style="western">
              <surname>Little</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Higgins</surname>
              <given-names>JPT</given-names>
            </name>
          </person-group>
          <source>The HuGENet™ HuGE Review Handbook, version 1.0</source>
          <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.hugenet.ca" xlink:type="simple">http://www.hugenet.ca</ext-link>. Accessed: 28 February 2006.</comment>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b021">
        <label>21</label>
        <element-citation publication-type="other" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Peters</surname>
              <given-names>JL</given-names>
            </name>
            <name name-style="western">
              <surname>Sutton</surname>
              <given-names>AJ</given-names>
            </name>
            <name name-style="western">
              <surname>Jones</surname>
              <given-names>DR</given-names>
            </name>
            <name name-style="western">
              <surname>Abrams</surname>
              <given-names>KR</given-names>
            </name>
            <name name-style="western">
              <surname>Rushton</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <source>Performance of tests and adjustments for publication bias in the presence of
            heterogeneity: Technical report 05–01</source>
          <publisher-loc>Leicester, England</publisher-loc>
          <publisher-name>Department of Health Sciences, University of Leicester</publisher-name>
          <comment>Report Number 05–01. pp.</comment>
          <fpage>1</fpage>
          <lpage>31</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b022">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bai</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2002</year>
          <article-title>Angiotensinogen and angiotensin-I converting enzyme gene variations in
            Chinese pregnancy induced hypertension.</article-title>
          <source>Hua Xi Yi Ke Da Xue Xue Bao</source>
          <volume>33</volume>
          <fpage>233</fpage>
          <lpage>237</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b023">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bouba</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Makrydimas</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Kalaitzidis</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Lolis</surname>
              <given-names>DE</given-names>
            </name>
            <name name-style="western">
              <surname>Siamopoulos</surname>
              <given-names>KC</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2003</year>
          <article-title>Interaction between the polymorphisms of the renin-angiotensin system in
            preeclampsia.</article-title>
          <source>Eur J Obstet Gynecol Reprod Biol</source>
          <volume>110</volume>
          <fpage>8</fpage>
          <lpage>11</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b024">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Choi</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Kang</surname>
              <given-names>JY</given-names>
            </name>
            <name name-style="western">
              <surname>Yoon</surname>
              <given-names>HS</given-names>
            </name>
            <name name-style="western">
              <surname>Han</surname>
              <given-names>SS</given-names>
            </name>
            <name name-style="western">
              <surname>Whang</surname>
              <given-names>CS</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2004</year>
          <article-title>Association of Angiotensin-converting enzyme and angiotensinogen gene
            polymorphisms with preeclampsia.</article-title>
          <source>J Korean Med Sci</source>
          <volume>19</volume>
          <fpage>253</fpage>
          <lpage>257</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b025">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Dizon-Townson</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Lompe</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Hastings</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Nelson</surname>
              <given-names>LM</given-names>
            </name>
            <name name-style="western">
              <surname>Varner</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1995</year>
          <article-title>A common genetic variant of the angiotensin converting enzyme is associated
            with both preeclampsia and chronic hypertension [abstract].</article-title>
          <source>Am J Obstet Gynecol</source>
          <volume>172</volume>
          <fpage>374</fpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b026">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Galao</surname>
              <given-names>AO</given-names>
            </name>
            <name name-style="western">
              <surname>de Souza</surname>
              <given-names>LH</given-names>
            </name>
            <name name-style="western">
              <surname>da Costa</surname>
              <given-names>BE</given-names>
            </name>
            <name name-style="western">
              <surname>Scheibe</surname>
              <given-names>RM</given-names>
            </name>
            <name name-style="western">
              <surname>de Figueiredo</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal
            pregnancy.</article-title>
          <source>Am J Obstet Gynecol</source>
          <volume>191</volume>
          <fpage>821</fpage>
          <lpage>824</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b027">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gurdol</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Isbilen</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Yilmaz</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Isbir</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Dirican</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>The association between preeclampsia and angiotensin-converting enzyme
            insertion/deletion polymorphism.</article-title>
          <source>Clin Chim Acta</source>
          <volume>341</volume>
          <fpage>127</fpage>
          <lpage>131</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b028">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Heiskanen</surname>
              <given-names>JT</given-names>
            </name>
            <name name-style="western">
              <surname>Pirskanen</surname>
              <given-names>MM</given-names>
            </name>
            <name name-style="western">
              <surname>Hiltunen</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Mannermaa</surname>
              <given-names>AJ</given-names>
            </name>
            <name name-style="western">
              <surname>Punnonen</surname>
              <given-names>KR</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2001</year>
          <article-title>Insertion-deletion polymorphism in the gene for angiotensin-converting
            enzyme is associated with obstetric cholestasis but not with preeclampsia.</article-title>
          <source>Am J Obstet Gynecol</source>
          <volume>185</volume>
          <fpage>600</fpage>
          <lpage>603</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b029">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kaur</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Jain</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Khuller</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Gupta</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Sherawat</surname>
              <given-names>BS</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Association of angiotensin-converting enzyme gene polymorphism with
            pregnancy-induced hypertension.</article-title>
          <source>Acta Obstet Gynecol Scand</source>
          <volume>84</volume>
          <fpage>929</fpage>
          <lpage>933</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b030">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kim</surname>
              <given-names>YJ</given-names>
            </name>
            <name name-style="western">
              <surname>Park</surname>
              <given-names>MH</given-names>
            </name>
            <name name-style="western">
              <surname>Park</surname>
              <given-names>HS</given-names>
            </name>
            <name name-style="western">
              <surname>Lee</surname>
              <given-names>KS</given-names>
            </name>
            <name name-style="western">
              <surname>Ha</surname>
              <given-names>EH</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2004</year>
          <article-title>Associations of polymorphisms of the angiotensinogen M235 polymorphism and
            angiotensin-converting-enzyme intron 16 insertion/deletion polymorphism with
            preeclampsia in Korean women.</article-title>
          <source>Eur J Obstet Gynecol Reprod Biol</source>
          <volume>116</volume>
          <fpage>48</fpage>
          <lpage>53</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b031">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kobashi</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Hata</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Shido</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Ohta</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Yamada</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2005</year>
          <article-title>Insertion/deletion polymorphism of the angiotensin-converting enzyme gene
            and preeclampsia in Japanese patients.</article-title>
          <source>Semin Thromb Hemost</source>
          <volume>31</volume>
          <fpage>346</fpage>
          <lpage>350</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b032">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Levesque</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Moutquin</surname>
              <given-names>JM</given-names>
            </name>
            <name name-style="western">
              <surname>Lindsay</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Roy</surname>
              <given-names>MC</given-names>
            </name>
            <name name-style="western">
              <surname>Rousseau</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Implication of an AGT haplotype in a multigene association study with
            pregnancy hypertension.</article-title>
          <source>Hypertension</source>
          <volume>43</volume>
          <fpage>71</fpage>
          <lpage>78</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b033">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mingwei</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Yamping</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Wehwei</surname>
              <given-names>Ch</given-names>
            </name>
          </person-group>
          <year>1998</year>
          <article-title>Study on a deletion polymorphism of the angiotensin converting enzyme gene
            in pregnancy induced hypertension.</article-title>
          <source>Chin J Obs Gynecol</source>
          <volume>33</volume>
          <fpage>83</fpage>
          <lpage>85</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b034">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Morgan</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Foster</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Hayman</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Crawshaw</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Baker</surname>
              <given-names>PN</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1999</year>
          <article-title>Angiotensin-converting enzyme insertion-deletion polymorphism in
            normotensive and pre-eclamptic pregnancies.</article-title>
          <source>J Hypertens</source>
          <volume>17</volume>
          <fpage>765</fpage>
          <lpage>768</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b035">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mozgovaia</surname>
              <given-names>EV</given-names>
            </name>
            <name name-style="western">
              <surname>Malysheva</surname>
              <given-names>OV</given-names>
            </name>
            <name name-style="western">
              <surname>Ivashchenko</surname>
              <given-names>TE</given-names>
            </name>
            <name name-style="western">
              <surname>Branov</surname>
              <given-names>VS</given-names>
            </name>
          </person-group>
          <year>2002</year>
          <article-title>Genetic predisposition to pre-eclampsia: Polymorphism of genes involved in
            regulation of endothelial functions.</article-title>
          <source>Balkan J Med Genetics</source>
          <volume>5</volume>
          <fpage>19</fpage>
          <lpage>26</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b036">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Roberts</surname>
              <given-names>CB</given-names>
            </name>
            <name name-style="western">
              <surname>Rom</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Moodley</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Pegoraro</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Hypertension-related gene polymorphisms in pre-eclampsia, eclampsia and
            gestational hypertension in Black South African women.</article-title>
          <source>J Hypertens</source>
          <volume>22</volume>
          <fpage>945</fpage>
          <lpage>948</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b037">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Roh</surname>
              <given-names>CR</given-names>
            </name>
            <name name-style="western">
              <surname>Kim</surname>
              <given-names>DK</given-names>
            </name>
            <name name-style="western">
              <surname>Yoon</surname>
              <given-names>BK</given-names>
            </name>
            <name name-style="western">
              <surname>Yang</surname>
              <given-names>SH</given-names>
            </name>
            <name name-style="western">
              <surname>Chung</surname>
              <given-names>JH</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1997</year>
          <article-title>A common genetic variant of the angiotensin converting enzyme (ACE) gene
            and pregnancy induced hypertensive disorders.</article-title>
          <source>Korean J Obstet Gynecol</source>
          <volume>40</volume>
          <fpage>1189</fpage>
          <lpage>1199</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b038">
        <label>38</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Seremak-Mrozikiewicz</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Drews</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Malewski</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Slomko</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Mrozikiewicz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>2000</year>
          <article-title>Polymorphic genotypes of the angiotensin-converting enzyme in severe
            pregnancy-induced hypertension.</article-title>
          <source>Arch Perinat Med</source>
          <volume>6</volume>
          <fpage>22</fpage>
          <lpage>24</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b039">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Tamura</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Johanning</surname>
              <given-names>GL</given-names>
            </name>
            <name name-style="western">
              <surname>Goldenberg</surname>
              <given-names>RL</given-names>
            </name>
            <name name-style="western">
              <surname>Johnston</surname>
              <given-names>KE</given-names>
            </name>
            <name name-style="western">
              <surname>DuBard</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <year>1996</year>
          <article-title>Effect of angiotensin-converting enzyme gene polymorphism on pregnancy
            outcome, enzyme activity, and zinc concentration.</article-title>
          <source>Obstet Gynecol</source>
          <volume>88</volume>
          <fpage>497</fpage>
          <lpage>502</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b040">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>HY</given-names>
            </name>
            <name name-style="western">
              <surname>Li</surname>
              <given-names>CM</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Yang</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Relationships between polymorphisms of angiotensin-converting enzyme and
            methylenetetrahydrofolate reductase genes and genetic susceptibility to
            pregnancy-induced hypertension.</article-title>
          <source>Zhonghua Fu Chan Ke Za Zhi</source>
          <volume>39</volume>
          <fpage>369</fpage>
          <lpage>372</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b041">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Watanabe</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Hamada</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Yamakawa-Kobayashi</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Yoshikawa</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Arinami</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <year>2001</year>
          <article-title>Evidence for an association of the R485K polymorphism in the coagulation
            factor V gene with severe preeclampsia from screening 35 polymorphisms in 27 candidate
            genes.</article-title>
          <source>Thromb Haemost</source>
          <volume>86</volume>
          <fpage>1594</fpage>
          <lpage>1595</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b042">
        <label>42</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Zhou</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Yu</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Huang</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <year>1999</year>
          <article-title>Detection of insertion/deletion polymorphism of angiotensin converting
            enzyme gene in preeclampsia.</article-title>
          <source>Chin J Med Genet</source>
          <volume>16</volume>
          <fpage>29</fpage>
          <lpage>31</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b043">
        <label>43</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kim</surname>
              <given-names>YJ</given-names>
            </name>
            <name name-style="western">
              <surname>Pang</surname>
              <given-names>MG</given-names>
            </name>
            <name name-style="western">
              <surname>Park</surname>
              <given-names>MY</given-names>
            </name>
            <name name-style="western">
              <surname>Park</surname>
              <given-names>MH</given-names>
            </name>
            <name name-style="western">
              <surname>Kim</surname>
              <given-names>YW</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2001</year>
          <article-title>A study on the association between angiotensinogen gene and
            angiotensin-converting-enzyme gene and pregnancy-induced hypertension in Korean women.</article-title>
          <source>Korean J Obstet Gynecol</source>
          <volume>44</volume>
          <fpage>1072</fpage>
          <lpage>1077</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b044">
        <label>44</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Seremak-Mrozikiewicz</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Drews</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Chmara</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Mrozikiewicz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>2001</year>
          <article-title>Polymorphism of gene angiotensin converting enzyme in pregnancy induced
            hypertension.</article-title>
          <source>Ginekol Pol</source>
          <volume>72</volume>
          <fpage>605</fpage>
          <lpage>610</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b045">
        <label>45</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Nalogowska-Glosnicka</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Lacka</surname>
              <given-names>BI</given-names>
            </name>
            <name name-style="western">
              <surname>Zychma</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Grzeszczak</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Zukowska-Szczechowska</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
            <collab xlink:type="simple">PIH Study Group</collab>
          </person-group>
          <year>2000</year>
          <article-title>Angiotensin II type 1 receptor gene A1166C polymorphism is associated with
            the increased risk of pregnancy-induced hypertension.</article-title>
          <source>Med Sci Monit</source>
          <volume>6</volume>
          <fpage>523</fpage>
          <lpage>529</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b046">
        <label>46</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Nalogowska-Glosnicka</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Lacka</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Zychma</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Grzeszczak</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Michalski</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1998</year>
          <article-title>Lack of relationship between angiotensinogen gene m235t polymorphism and
            gene insertion/deletion (I/D-intron 16) and Pst I RFLP (P/M-intron 7) polymorphisms of
            the angiotensin I converting enzyme (ACE) gene and the development of H-gestosis.
            Preliminary results.</article-title>
          <source>Pol Arch Med Wewn</source>
          <volume>100</volume>
          <fpage>19</fpage>
          <lpage>26</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b047">
        <label>47</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Zhu</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Xia</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Cheng</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <year>1998</year>
          <article-title>Study on a deletion polymorphism of the angiotensin converting enzyme gene
            in pregnancy induced hypertension.</article-title>
          <source>Zhonghua Fu Chan Ke Za Zhi</source>
          <volume>33</volume>
          <fpage>83</fpage>
          <lpage>85</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b048">
        <label>48</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Huang</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Liao</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Sun</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <year>2001</year>
          <article-title>Study on the relation between the angiotensin converting enzyme gene and
            pregnancy induced hypertension.</article-title>
          <source>Zhonghua Fu Chan Ke Za Zhi</source>
          <volume>36</volume>
          <fpage>15</fpage>
          <lpage>17</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b049">
        <label>49</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mello</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Parretti</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Fatini</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Riviello</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Gensini</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2005</year>
          <article-title>Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and
            restores the physiological vascular changes in angiotensin-converting enzyme DD women.</article-title>
          <source>Hypertension</source>
          <volume>45</volume>
          <fpage>86</fpage>
          <lpage>91</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b050">
        <label>50</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ioannidis</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Trikalinos</surname>
              <given-names>TA</given-names>
            </name>
            <name name-style="western">
              <surname>Ntzani</surname>
              <given-names>EE</given-names>
            </name>
            <name name-style="western">
              <surname>Contopoulos-Ioannidis</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <year>2003</year>
          <article-title>Genetic associations in large versus small studies: An empirical
            assessment.</article-title>
          <source>Lancet</source>
          <volume>361</volume>
          <fpage>567</fpage>
          <lpage>571</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b051">
        <label>51</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ioannidis</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Trikalinos</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Early extreme contradictory estimates may appear in published research: The
            Proteus phenomenon in molecular genetics research and randomized trials.</article-title>
          <source>J Clin Epidemiol</source>
          <volume>58</volume>
          <fpage>543</fpage>
          <lpage>549</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b052">
        <label>52</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Pan</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Trikalinos</surname>
              <given-names>TA</given-names>
            </name>
            <name name-style="western">
              <surname>Kavvoura</surname>
              <given-names>FK</given-names>
            </name>
            <name name-style="western">
              <surname>Lau</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Ioannidis</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Local literature bias in genetic epidemiology: An empirical evaluation of
            the Chinese literature.</article-title>
          <source>PLoS Med</source>
          <volume>2</volume>
          <elocation-id>e334.</elocation-id>
          <comment>doi:<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0020334" xlink:type="simple">10.1371/journal.pmed.0020334</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b053">
        <label>53</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Healy</surname>
              <given-names>DG</given-names>
            </name>
            <name name-style="western">
              <surname>Abou-Sleiman</surname>
              <given-names>PM</given-names>
            </name>
            <name name-style="western">
              <surname>Casas</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Ahmadi</surname>
              <given-names>KR</given-names>
            </name>
            <name name-style="western">
              <surname>Lynch</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2006</year>
          <article-title>UCHL-1 is not a Parkinson's disease susceptibility gene.</article-title>
          <source>Ann Neurol</source>
          <volume>59</volume>
          <fpage>627</fpage>
          <lpage>633</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b054">
        <label>54</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ioannidis</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Gwinn</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Little</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Higgins</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Bernstein</surname>
              <given-names>JL</given-names>
            </name>
            <etal/>
            <collab xlink:type="simple"> Human Genome Epidemiology Network and the Network of Investigator
            Networks</collab>
          </person-group>
          <year>2006</year>
          <article-title>A road map for efficient and reliable human genome epidemiology.</article-title>
          <source>Nat Genet</source>
          <volume>38</volume>
          <fpage>3</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b055">
        <label>55</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Yu</surname>
              <given-names>CK</given-names>
            </name>
            <name name-style="western">
              <surname>Casas</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Savvidou</surname>
              <given-names>MD</given-names>
            </name>
            <name name-style="western">
              <surname>Sahemey</surname>
              <given-names>MK</given-names>
            </name>
            <name name-style="western">
              <surname>Nicolaides</surname>
              <given-names>KH</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2006</year>
          <article-title>Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and
            development of pre-eclampsia: A case-control study and a meta-analysis.</article-title>
          <source>BMC Pregnancy Childbirth</source>
          <volume>6</volume>
          <fpage>7</fpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b056">
        <label>56</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lin</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>August</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Genetic thrombophilias and preeclampsia: A meta-analysis.</article-title>
          <source>Obstet Gynecol</source>
          <volume>105</volume>
          <fpage>182</fpage>
          <lpage>192</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b057">
        <label>57</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Cardon</surname>
              <given-names>LR</given-names>
            </name>
            <name name-style="western">
              <surname>Bell</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <year>2001</year>
          <article-title>Association study designs for complex diseases.</article-title>
          <source>Nat Rev Genet</source>
          <volume>2</volume>
          <fpage>91</fpage>
          <lpage>99</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b058">
        <label>58</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rumbold</surname>
              <given-names>AR</given-names>
            </name>
            <name name-style="western">
              <surname>Crowther</surname>
              <given-names>CA</given-names>
            </name>
            <name name-style="western">
              <surname>Haslam</surname>
              <given-names>RR</given-names>
            </name>
            <name name-style="western">
              <surname>Dekker</surname>
              <given-names>GA</given-names>
            </name>
            <name name-style="western">
              <surname>Robinson</surname>
              <given-names>JS</given-names>
            </name>
            <collab xlink:type="simple">ACTS Study Group</collab>
          </person-group>
          <year>2006</year>
          <article-title>Vitamins C and E and the risks of preeclampsia and perinatal complications.</article-title>
          <source>N Engl J Med</source>
          <volume>354</volume>
          <fpage>1796</fpage>
          <lpage>1806</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b059">
        <label>59</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Poston</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Briley</surname>
              <given-names>AL</given-names>
            </name>
            <name name-style="western">
              <surname>Seed</surname>
              <given-names>PT</given-names>
            </name>
            <name name-style="western">
              <surname>Kelly</surname>
              <given-names>FJ</given-names>
            </name>
            <name name-style="western">
              <surname>Shennan</surname>
              <given-names>AH</given-names>
            </name>
            <collab xlink:type="simple">Vitamins in Pre-eclampsia (VIP) Trial Consortium</collab>
          </person-group>
          <year>2006</year>
          <article-title>Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP
            trial): Randomised placebo-controlled trial.</article-title>
          <source>Lancet</source>
          <volume>367</volume>
          <fpage>1145</fpage>
          <lpage>1154</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b060">
        <label>60</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Villar</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Abdel-Aleem</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Merialdi</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Mathai</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Ali</surname>
              <given-names>MM</given-names>
            </name>
            <etal/>
            <collab xlink:type="simple"> World Health Organization Calcium Supplementation for the Prevention of
              Preeclampsia Trial Group</collab>
          </person-group>
          <year>2006</year>
          <article-title>World Health Organization randomized trial of calcium supplementation among
            low calcium intake pregnant women.</article-title>
          <source>Am J Obstet Gynecol</source>
          <volume>194</volume>
          <fpage>639</fpage>
          <lpage>649</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b061">
        <label>61</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Levine</surname>
              <given-names>RJ</given-names>
            </name>
            <name name-style="western">
              <surname>Hauth</surname>
              <given-names>JC</given-names>
            </name>
            <name name-style="western">
              <surname>Curet</surname>
              <given-names>LB</given-names>
            </name>
            <name name-style="western">
              <surname>Sibai</surname>
              <given-names>BM</given-names>
            </name>
            <name name-style="western">
              <surname>Catalano</surname>
              <given-names>PM</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1997</year>
          <article-title>Trial of calcium to prevent preeclampsia.</article-title>
          <source>N Engl J Med</source>
          <volume>337</volume>
          <fpage>69</fpage>
          <lpage>76</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b062">
        <label>62</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Hingorani</surname>
              <given-names>AD</given-names>
            </name>
            <name name-style="western">
              <surname>Shah</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Casas</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <article-title>Linking observational and genetic approaches to determine the role of
            C-reactive protein in heart disease risk.</article-title>
          <source>Eur Heart J</source>
          <volume>27</volume>
          <fpage>1261</fpage>
          <lpage>1263</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b063">
        <label>63</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Hingorani</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Humphries</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Nature's randomised trials.</article-title>
          <source>Lancet</source>
          <volume>366</volume>
          <fpage>1906</fpage>
          <lpage>1908</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b064">
        <label>64</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ioannidis</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <article-title>Journals should publish all “null” results and should
            sparingly publish “positive” results.</article-title>
          <source>Cancer Epidemiol Biomarkers Prev</source>
          <volume>15</volume>
          <fpage>186</fpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b065">
        <label>65</label>
        <element-citation publication-type="other" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Veitch</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <source>Introducing PLoS Clin trials</source>
          <volume>1</volume>
          <elocation-id>e8.</elocation-id>
          <comment>doi: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pctr.0010008" xlink:type="simple">10.1371/journal.pctr.0010008</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b066">
        <label>66</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <year>2000</year>
          <article-title>Report of the National High Blood Pressure Education Program Working Group
            on High Blood Pressure in Pregnancy.</article-title>
          <source>Am J Obstet Gynecol</source>
          <volume>183</volume>
          <fpage>S1</fpage>
          <lpage>S22</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b067">
        <label>67</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Brown</surname>
              <given-names>MA</given-names>
            </name>
            <name name-style="western">
              <surname>de Swiet</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <year>1999</year>
          <article-title>Classification of hypertension in pregnancy.</article-title>
          <source>Baillieres Best Pract Res Clin Obstet Gynaecol</source>
          <volume>13</volume>
          <fpage>27</fpage>
          <lpage>39</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b068">
        <label>68</label>
        <element-citation publication-type="other" xlink:type="simple">
          <article-title>National High Blood Pressure Education Program Working Group Report on High
            Blood Pressure in Pregnancy (1990).</article-title>
          <source> Am J Obstet Gynecol</source>
          <volume>163</volume>
          <fpage>1691</fpage>
          <lpage>1712</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b069">
        <label>69</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Helewa</surname>
              <given-names>ME</given-names>
            </name>
            <name name-style="western">
              <surname>Burrows</surname>
              <given-names>RF</given-names>
            </name>
            <name name-style="western">
              <surname>Smith</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Williams</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Brain</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1997</year>
          <article-title>Report of the Canadian Hypertension Society Consensus Conference: 1.
            Definitions, evaluation and classification of hypertensive disorders in pregnancy.</article-title>
          <source>Can Med Assoc J</source>
          <volume>157</volume>
          <fpage>715</fpage>
          <lpage>725</lpage>
        </element-citation>
      </ref>
      <ref id="pmed-0030520-b070">
        <label>70</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <collab xlink:type="simple">Committee on Technical Bulletins of the American College of Obstetricians and
            Gynecologists</collab>
          <year>1996</year>
          <article-title>ACOG technical bulletin. Hypertension in pregnancy. Number
            219—January 1996 (replaces number 91, February 1986).</article-title>
          <source>Int J Gynaecol Obstet</source>
          <volume>53</volume>
          <fpage>175</fpage>
          <lpage>183</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>